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1. SUMMARY 
Imprinted genes play important roles in brain development. As the neural 
developmental capabilities of human parthenogenetic embryonic stem cells 
(hpESCs) with only a maternal genome were not assessed in great detail, hence 
here the potential of hpESCs to differentiate into various neural subtypes was 
determined. In addition DNA methylation and expression of imprinted genes upon 
neural differentiation was also investigated.  
The results demonstrated that hpESC-derived neural stem cells (hpNSCs) showed 
expression of NSC markers Sox1, Nestin, Pax6, and Musashi1 (MS1), the silencing 
of pluripotency genes (Oct4, Nanog) and the absence of activation of neural crest 
(Snai2, FoxD3) and mesodermal (Acta1) markers. Moreover, confocal images of 
hpNSC cultures exhibited ubiquitous expression of NSC markers Nestin, Sox1, Sox2 
and Vimentin. Differentiating hpNSCs for 28 days generated neural subtypes with 
neural cell type-specific morphology and expression of neuronal and glial markers, 
including Tuj1, NeuN, Map2, GFAP, O4, Tau, Synapsin1 and GABA. hpNSCs also 
responded to region-specific differentiation signals and differentiated into regional 
phenotypes such as midbrain dopaminergic- and motoneuron-type cells. hpESC-
derived neurons showed typical neuronal Na+/K+ currents in voltage clamp mode, 
elicited multiple action potentials with a maximum frequency of 30 Hz. Cell depicted 
a typical neuron-like current pattern that responded to selective pharmacological 
blockers of sodium (tetrodotoxin) and potassium (tetraethylammonium) channels. 
Furthermore, in hpESCs and hpNSCs the majority of CpGs of the differentially 
methylated regions (DMRs) KvDMR1 were methylated whereas DMR1 (H19/Igf2 
locus) showed partial or complete absence of CpG methylation, which is consistent 
with a parthenogenetic (PG) origin. Upon differentiation parent-of-origin-specific 
gene expression was maintained in hpESCs and hpNSCs as demonstrated by 
imprinted gene expression analyses. 
Together this shows that despite the lack of a paternal genome, hpNSCs are 
proficient in differentiating into glial- and neuron-type cells, which exhibit electrical 
activity similar to newly formed neurons. Moreover, maternal-specific gene 
expression and imprinting-specific DNA-methylation are largely maintained upon 
neural differentiation. hpESCs are a means to generate histocompatible and disease 
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allele-free ESCs. Additionally, hpESCs are a unique model to study the influence of 
imprinting on neurogenesis.  
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2. ZUSAMMENFASSUNG 
Imprinted Gene spielen eine wichtige Rolle bei der Gehirnentwicklung. Da das 
neurale Entwicklungspotenzial von hpESCs bisher noch nicht ausführlich untersucht 
wurde, war das Ziel dieser Arbeit das Differenzierungspotenzial von hpESCs zu 
verschiedenen neuralen Subtypen zu untersuchen. Außerdem wurden die DNA-
Methylierung und Expression imprinted Gene in hpESCs während der neuralen 
Differenzierung analysiert.  
Die Ergebnisse zeigten, dass von hpESCs abgeleitete neurale Stammzellen 
(hpNSCs) die NSC-Marker Sox1, Nestin, Pax6 und Musashi1 (MS1) exprimierten,  
Pluripotenzmarker-Gene (Oct4, Nanog) abschalteten und keine Aktivierung von 
Markern der Neuralleistenzellen (Snai2, FoxD3) sowie dem mesodermalen Marker 
Acta1 stattfand. Immunfärbungen zeigten weiterhin, dass aus hpESCs abgeleitete 
Stammzellen die NSC-Marker Nestin, Sox1, Sox2 und Vimentin auf Proteinebene 
exprimierten. Durch gerichtete neurale Differenzierung für 28 Tage konnten aus 
hpESCs neurale Subtypen abgeleitet werden, die eine neurale Zelltyp-spezifische 
Morphologie aufweisen und positiv für neuronale und gliale Marker wie Tuj1, NeuN, 
Map2, GFAP, O4, Tau, Synapsin1 und GABA sind. Um aus hpNSCs dopaminerge 
und Motoneuronen abzuleiten, wurden während der Differenzierung Morphogene 
und trophische Faktoren zugegeben. Elektrophysiologische Analysen konnten 
zeigen, dass die in vitro differenzierten Neuronen, die von hpESCs abgeleitet 
wurden, für Neurone typische Na+/K+ Ströme sowie Aktionspotentiale (30 Hz) 
vorweisen ausbilden und auf ausgewählte pharmakologische Natrium- (Tetrodotoxin) 
und Kalium- (Tetraethylammonium) Kanal-Blocker reagierten. 
Desweiteren war der Großteil der CpGs von differentiell methylierten Regionen 
(DMRs) KvDMR1 in hpESCs und hpNSCs methyliert, während DMR1 (H19/Igf2 
Locus) eine partiell oder komplett abwesende CpG-Methylierung zeigte, was dem 
parthenogenetischen Ursprung entspricht. Während der Differenzierung wurde die 
elternabhängige (parent-of-origin) spezifische Genexpression in hpESCs und 
hpNSCs aufrechterhalten, wie mit Genexpressionsanalysen imprinted Gene gezeigt 
werden konnte.  
In der Summe zeigen die hier dargestellten Ergebnisse, dass hpESCs, die kein 
paternales Genom besitzen, keine Beeinträchtigung im neuralen 
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Differenzierungspotential zeigten und zu Gliazellen und Neurone differenziert 
werden konnten. Elektrophysiologische Analysen zeigten ferner, dass von hpESCs 
abgeleitete Neurone funktionell sind. Zudem wird die Expression maternal-
spezifischer Gene und die Imprinting-spezifische DNA-Methylierung während der 
Differenzierung größtenteils aufrechterhalten. In der Summe stellen hpESCs ein 
einzigartiges Modell dar, um den Einfluss des Imprintings auf die Neurogenese zu 
untersuchen. 
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3. ABBREVIATIONS 
AG  androgenetic 
ASCs            adult stem cells 
BDNF  brain-derived neurotrophic factor 
BSA  bovine serum albumin 
bFGF2  basic fibroblast growth factor 2 
cDNA  complementary deoxyribonucleic acid 
cAMP  cyclic adenosine monophosphate 
6-DMAP 6-dimethylaminopurine 
DAPI  4,6-diamidino-2-phenylindole 
DEPC  diethylpyrocabonate 
DMSO dimethyl sulfoxide 
DMEM dulbecco's modified eagle medium 
DNA  deoxyribonucleic acid  
dNTP  deoxynucleotide triphosphate 
EB  embryoid bodies 
EDTA  ethylenediaminetetraacetic acid 
ESC  embryonic stem cell 
EGF  epidermal growth factor 
et al.  et alii (masculine plural) or et aliae (feminine plural), and others 
FCS  fetal calf serum 
FGF8b fibroblast growth factor 8b 
GG  gynogenetic 
GDNF  glial cell-derived neurotrophic factor 
hESCs  human embryonic stem cells 
hNSCs  human neural stem cells 
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hpESCs human parthenogenetic embryonic stem cells 
hpNSCs human parthenogenetic neural stem cells 
ICM  inner cell mass (of blastocyst) 
iPS cells induced pluripotent stem cells 
IVF  in vitro fertilisation 
KSR  knockout serum replacement 
max  maximum 
min  minimum 
N  biparental (normally fertilised) 
NEAA  non-essential amino acids 
NSCs  neural stem cells 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PFA  paraformaldehyde 
PG  parthenogenetic 
RCF  relative centrifugal force 
RNA  ribonucleic acid 
rpm  revolutions per minute 
RT- PCR real time polymerase chain reaction 
SDS  sodium dodecyl sulfate 
SHH  sonic hedgehog homolog 
UBS   umbilical cord blood serum 
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4. INTRODUCTION 
4.1 Stem cells: features and functions 
The single celled embryo, the zygote, is formed when the oocyte is fertilized by a 
sperm. In vertebrates the zygote and early blastomere are considered to be 
totipotent as characterised by the ability to develop into a complete embryo including 
the placenta (Mitalipov et al., 2009). Every individual totipotent cell is a self-
contained entity which can develop into a complete organism. The cells of later 
developmental stages lose the totipotent property. With the progression of embryonic 
development beyond the 8-cell stage or later (varies in different species), 
blastomeres lose their totipotent characteristics (Fig. 1) (Hemmat et al., 2010). 
The cells derived from the inner cell mass (ICM) of the blastocyst stage embryo, are 
limited in their differentiation capability and thus are pluripotent in nature (Fig. 1). 
Embryonic stem cells (ESCs) are isolated from the ICM of preimplantation embryos 
(Evans et al., 1981; Martin 1981). Surprisingly, in vitro ESCs maintain embryo-
seeding and germline-transmission capacity together with self-renewal and 
pluripotent potential. Other hallmarks of ESCs are the expression of telomerase that 
prevents shortening of DNA during repetitive replication cycles and the ability to 
sustain a stable karyotype after numerous divisions. ESCs are the prototype of 
pluripotent stem cells. 
Notably, a transient totipotent cell population was identified within mouse ES and 
induced pluripotent stem (iPS) cell cultures which possessed the capability to 
differentiate into embryonic and extra-embryonic tissues (Macfarlan et al., 2012). 
These ESCs showed high expression levels of transcripts that are usually expressed 
in the totipotent two-cell embryos (Macfarlan et al., 2012). This may point towards a 
transient state ESCs pass through, during which they can form all the tissue types of 
an organism, including placental cells (Surani et al., 2012). 
In many adult tissues stem cells are the only permanently present cell types, as 
differentiated cells have a limited life span and therefore have to be continuously 
replaced (Young et al., 2004; Hemmat et al., 2010). These stem cells are known as 
somatic/adult stem cells (ASCs). ASCs are multi- or unipotent as they can give rise 
to various specialized cell types of one organ system (Poulsom et al., 2002). 
Therefore, ASCs are lineage-restricted. ASCs divide symmetrically or asymmetrically 
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(Forbes et al., 2002; Tsai et al., 2002) and mostly exist in a quiescent state; hence 
they divide infrequently (Li et al., 2010). 
Due to their unique developmental potential mentioned above stem cells are crucial 
for embryonic development and adult tissue homeostasis. Stem cells are also 
valuable tools for basic and applied research areas such as developmental biology, 
drug discovery, development of diagnostics, stem-cell-based therapies, modelling 
and understanding disease origin and progression. 
 
 
 
Fig. 1 Developmental potential of stem cells.  
Embryonic development starts with the formation of the zygote. The zygote and each 
blastomere till the 4 cell stage are considered to be totipotent (Mitalipov et al., 2009). 
As development proceeds, the developmental potential decreases resulting in 
pluripotent ICM cells of the blastocyst from which the ESCs are derived. The 
developmental ability further declines subsequently resulting in multipotent, unipotent 
and differentiated cells (adapted from Mitalipov et al., 2009). 
 
4.1.1 Human embryonic stem cells  
Human embryonic stem cells (hESCs) are derived from the ICM of human 
blastocysts (Thomson et al., 1998). Similar to mouse ESCs, hESCs can be cultured 
and expanded in vitro. hESCs possess analogous properties to ICM cells such as 
self-renewal and pluripotency, the hallmarks of ESCs. To identify the in vivo 
differentiation ability of hESC lines, teratoma formation in mice is considered to be a 
stringent method. hESCs when injected into immunodeficient mouse develop 
teratomas containing derivatives from the three germ layers. Using hESCs in the 
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teratoma assay demonstrate that hESCs maintained their three germ layer 
differentiation potential when cultured in vitro (Thomson et al., 1998). 
Under differentiation conditions, hESCs can generate any of the 200 cell types 
present in the adult body (Yu et al., 2008). In vitro expansion of hESCs as a 
pluripotent population requires culturing on fibroblast feeder cells and 
supplementation with fibroblast growth factor 2 (FGF-2).  
FGF signalling is critical for hESC self-renewal and is required to maintain hESCs in 
an undifferentiated state (Eiselleova et al., 2009; Zoumaro-Djayoon et al., 2011). 
Along with FGF signalling, TGF/Activin/Nodal signalling is essential for hESCs 
(Beattie et al., 2005; James et al., 2005; Vallier et al., 2005). FGF-2 indirectly acts on 
fibroblast feeder cells to modulate transforming growth factor b1 (TGFβ1) and activin 
A signalling, which are growth factors that promote self-renewal along with FGF-2 
(Greber et al., 2007). FGF-2 was shown to activate the mitogen-activated protein 
kinase (MAPK) pathway (Li et al., 2007). Moreover, FGF-2 induces the production of 
TGFβ and insulin-like growth factor-II (IGF-II) (Bendall et al., 2007). Bendall et al., 
2007 also observed that FGF-2 regulates the hESC niche including hESC-derived 
fibroblast-like cells which support self-renewal of hESCs. Furthermore, FGF-2 
signalling regulates NANOG promoter activity which supports hESCs proliferation in 
an undifferentiated state (Xu et al., 2008). On the contrary, leukemia inhibitory factor 
(LIF) is required for long-term maintenance of mouse ESCs (Evans et al., 1981; 
Martin 1981). Thus, it seems that human and mouse ESCs differ. Further proteomic, 
transcriptomic, epigenetic and cell culture analyses indicated that hESCs are similar 
to mouse epiblast-derived stem cells (Brons et al., 2007; Tesar et al., 2007). 
Similar to the transient pluripotent cells found in an embryo, hESCs express stage-
specific markers, embryonic antigens, alkaline phosphatase and telomerase 
activities, together with genes responsible for maintaining the molecular pluripotency 
network. A unique core transcriptional regulatory circuit is responsible for the 
regulation of the pluripotency network in hESCs which comprises of the transcription 
factors Oct4, Sox2 and Nanog (Chambers et al., 2009; Kashyap et al., 2009; Ng et 
al., 2011). Polycomb repressive complexes (PRC1 and PRC2) and stem cell-related 
microRNA are involved with Oct4, Sox2 and Nanog in a complex regulatory 
mechanism controlling the unique features of ESCs (Kashyap et al., 2009; Ng et al., 
2011). 
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The properties mentioned above make hESCs a promising source for future 
regenerative applications. By now some hESC-based therapies have reached 
clinical trials (Goldring et al., 2011). So far results of only some of these clinical trials 
are published. Schwartz et al., 2012 reported the safe engraftment of hESC-derived 
retinal pigment epithelium cells into patients suffering from macular degeneration 
with no signs of hyperproliferation, tumorigenicity, ectopic tissue formation or graft 
rejection (Schwartz et al., 2012). However, the road ahead for the application of 
hESCs in regenerative medicine remains long and tortuous. One of the major 
concerns for the clinical application of hESCs is that transplantation of hESC-derived 
cells evokes an immune response from the host body (Muller et al., 2009; Tang et 
al., 2011). This might lead to graft rejection (Muller et al., 2009; Tang et al., 2011). 
Hence there is the need to develop approaches for the derivation of histocompatible 
pluripotent stem cells. 
 
4.1.2 Nuclear reprogramming 
 
Development from a pluripotent stem cell to a differentiated cell was for a long time 
considered as a one-way road. But surprisingly, differentiated cells can be reverted 
into pluripotent cells using specific conditions. This process is known as nuclear 
reprogramming. The genetic and epigenetic changes needed for reversing the 
developmental process can be achieved by two principal approaches: somatic cell 
nuclear transfer (SCNT) (Wilmut et al., 1997) and induced reprogramming using 
ectopic gene expression (Takahashi et al., 2006). 
SCNT requires removal of the nucleus from an unfertilized oocyte or a recently 
fertilized zygote and replacement by the nucleus of a somatic cell (Campbell et al., 
2007). This technology is successful in a variety of mammals such as mice 
(Wakayama et al., 1998), cattle (Cibelli et al., 1998; Kato et al., 1998), pigs 
(Polejaeva et al., 2000), goats (Baguisi et al., 1999), rabbits (Chesne et al., 2002), 
cats (Shin et al., 2002), mules (Woods et al., 2003), horses (Galli et al., 2003), rats 
(Zhou et al., 2003), and dogs (Lee et al., 2005). So far it seems that SCNT is not 
successfully applicable with human cells. The human SCNT embryos were not able 
to cleave properly; as a result the embryos were arrested at early cleavage stages 
and were unable to develop into blastocysts (Stojkovic et al., 2005; Cibelli 2007). In 
2004 Hwang et al. claimed that they successfully produced SCNT-derived hESCs. 
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However this report was later retracted because of fabrication of data and the SCNT-
derived hESCs were later found to be PG in origin (Kim et al., 2007). Recently 
Noggle et al., 2011 reported that adding the nucleus of a differentiated adult cell into 
a haploid oocyte allowed the growth of the oocyte till the blastocyst stage which, lead 
to the derivation of triploid pluripotent stem cells. However, critical limitations are 
required to overcome for the derivation of diploid hESCs by SCNT (Daley et al., 
2011; de Souza 2011).  
Murine iPS cells were first derived by reprogramming somatic cells by ectopic 
expression of four transcription factors: Oct4, Sox2, Myc and Klf4 (Takahashi et al., 
2006). Human iPS cells were generated by two independent research groups using 
a set of different transcription factors: Oct4, Sox2, Myc and Klf4 (Takahashi et al., 
2007) or Oct4, Sox2, Nanog and Lin28 (Yu et al., 2007). These human iPS cells 
express ESC-specific markers, differentiate into multiple lineages in vitro, and form 
teratomas containing cell types of all three germ layers. iPS cells are a potential 
source of histocompatible patient-specific pluripotent stem cells for future 
regenerative applications. Clinical trials of human iPS cells in regenerative medicine 
are at an early stage (Lengner 2010; Vitale et al., 2011). However, many obstacles 
have to be crossed before iPS cells can be considered to be used as therapeutics. 
Several analyses indicate that iPS cells are similar to ESCs including differentiation 
capacity, gene expression and chromatin modification profiles (Puri et al., 2012). But 
still there are considerable number of reports that point out differences between 
ESCs and iPS cells. For example, various reports showed differences between 
hESCs and iPS cells in gene expression (Chin et al., 2009), DNA methylation (Doi et 
al., 2009) and differentiation potential (Hu et al., 2010). Also, iPS cells maintain 
epigenetic memories of somatic cells after reprogramming (Barrero et al., 2011; Ohi 
et al., 2011; Panopoulos et al., 2011). Nevertheless, iPS cells not only provide a tool 
for researchers to understand the mechanistic basis of diseases, but also offer the 
possibility of in vitro drug testing and deciphering the molecular processes of 
reprogramming and differentiation (Kiskinis et al., 2010). 
 
4.1.3 Germline stem cells 
Earlier studies suggested that primordial germ cells derived from midgestation 
embryos had similar pluripotent characteristics as ESCs (Donovan et al., 2003). 
Studies in mice (Kanatsu-Shinohara et al., 2004; Guan et al., 2006; Moraveji et al., 
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2012) and humans (Conrad et al., 2008) showed that pluripotent germline stem cells 
(GSCs) can be derived from neonatal and adult testis. GSCs in adult testis are 
suggested to be derived from spermatogonial stem cells (Guan et al., 2006; Conrad 
et al., 2008). Spermatogonial stem cells can be enriched by culturing them with 
specific cytokines and extracellular matrix proteins (for example laminin) followed by 
fluorescence-activated cell sorting with antibodies specific for cell-surface 
pluripotency markers. Culturing sorted cells in the presence of LIF enables the 
derivation of pluripotent GSC lines (Guan et al., 2006; Conrad et al., 2008). The 
generation of GSCs from spermatogonial stem cells probably happens due to the 
initiation of a reprogramming process caused by the culture conditions (Conrad et 
al., 2008; Kimura et al., 2011). Similar to ESCs and iPS cells, GSCs can differentiate 
into tissues of all three germ layers in embryoid bodies and teratoma analyses (Kee 
et al., 2010). However, further validation of GSCs is needed to evaluate their 
potential for clinical uses, particularly given that they carry two copies of paternal 
genome and therefore have only paternal imprint. 
 
4.2 Pluripotent uniparental stem cells: generation and developmental potential  
Pluripotent uniparental stem cells are diploid and carry copies of either paternal or 
maternal genomes. Cells, which inherited genetic material only from the maternal 
side, are called gynogenetic (GG) or PG cells. Conversely, androgenetic (AG) cells 
carry two copies of the paternal genome (Barton et al., 1984; McGrath et al., 1984).  
 
4.2.1 Androgenetic ESCs 
AG ESCs are generated from AG blastocyst. AG embryo generation by pronuclear 
transfer involves the reciprocal exchange of maternal with paternal pronuclei from 
two zygotes, resulting in embryos with two paternal genomes from different zygotes 
(McGrath et al., 1983). Mammalian AG embryos cease development at an early 
embryonic stage (Barton et al., 1984; McGrath et al., 1984). Despite the inability of 
full development, AG embryos reach the blastocyst stage from which ESCs can be 
produced (Mann et al., 1990; Eckardt et al., 2007). AG ESCs have been derived 
from a variety of mammals such as mice (McGrath et al., 1984; Surani et al., 1984; 
Eckardt et al., 2007) and bovine (Lagutina et al., 2004). However, until now there are 
no reports on the derivation of human AG ESCs. 
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4.2.2 Parthenogenetic ESCs 
Pluripotent uniparental stem cells that contain the maternal genome only can be GG 
and PG derived. Murine GG embryos are generated by exchanging paternal 
pronuclei with maternal pronuclei from two zygotes. Conversely, parthenogenetic 
human embryonic stem cells (hpESCs) are obtained from oocytes that undergo 
artificial in vitro parthenogenesis (Kim et al., 2007; Lin et al., 2007; Mai et al., 2007; 
Revazova et al., 2007). The development of offspring from an oocyte without male 
genetic contribution is known as parthenogenesis. The oocyte is activated by 
exposure to ionomycin that mimics the calcium waves produced by sperm entry 
during normal fertilization (Nakagawa et al., 2001; Paffoni et al., 2008). The increase 
in intracellular calcium ionophore simulates the biochemical events caused by sperm 
penetration that triggers the oocyte into further development (Nakagawa et al., 2001; 
Paffoni et al., 2008). The extrusion of the polar body at meiotic divisions is prevented 
by 6-dimethylaminopurine (6-DMAP) leading to the derivation of a blastocyst with 
two copies of the maternal genome (Brevini et al., 2008; Paffoni et al., 2008). 
Parthenogenesis occurs naturally in some invertebrate species and in vertebrates 
like lizards, birds and fish (Lampert et al., 2008; Neaves et al., 2011). Even though 
mammals are not capable of reproducing by parthenogenesis, PG ESCs can be 
derived from PG blastocyst originating from artificial activation of oocytes. However 
in mammals, PG embryos do not develop to adulthood majorly due to the absence of 
a paternal genome (Kono et al., 2004; Solter 2006). PG ESCs have been isolated 
from several species such as mouse (Kaufman et al., 1983; Surani et al., 1986; Kim 
et al., 2007; Eckardt et al., 2011), rabbit (Fang et al., 2006; Wang et al., 2007), pig 
(Brevini et al., 2010), sheep (Nandedkar et al., 2009), bovine (Pashaiasl et al., 2010), 
buffalo (Sritanaudomchai et al., 2007) and monkey (Marshall et al., 1998; Cibelli et 
al., 2002; Vrana et al., 2003; Dighe et al., 2008; Wei et al., 2011). In addition, the 
derivation of pluripotent human ESCs from PG blastocysts were described (Kim et 
al., 2007; Lin et al., 2007; Mai et al., 2007; Revazova et al., 2007).  
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Fig. 2 Schematic representation of in vitro parthenogenetic activation of 
human oocytes. Human oocytes can be stimulated to divide by ionomycin and 6-
DMAP exposure. hpESCs can be derived from the ICM of PG blastocysts (adapted 
from Brevini et al., 2008). 
 
4.2.3 Developmental capabilities of uniparental cells 
In general mouse uniparental embryos do not develop past the late somite stages. 
AG embryos barely grow past early developmental stages, with an impeded growth 
of the embryo proper and a relatively well developed trophoblast (Barton et al., 
1984). On the other hand, PG embryos rarely develop to late somite stages. PG 
embryos are largely deprived of extraembryonic tissues (Kaufman et al., 1977; 
Surani et al., 1983). To better analyse the developmental potential of uniparental 
murine ESCs, chimeras were produced either by aggregating preimplantation stage 
embryos of biparental (N) with AG or PG cleavage stage blastomeres or by injecting 
AG or PG ICM cells or ESCs into biparental  blastocysts (Nagy et al., 1989; Fundele 
et al., 1990; Barton et al., 1991). The analysis of chimeras revealed that uniparental 
ICM cells and ESCs contributed to all tissues of mice, including germline cells (Nagy 
et al., 1989; Fundele et al., 1990; Barton et al., 1991). However, AG and PG 
favoured specific differentiation pathways (Nagy et al., 1989; Fundele et al., 1990; 
Barton et al., 1991). While AG cells were present in mesoderm-derived tissues, PG 
cells were mostly found in brain and occasionally in tissues derived from mesoderm 
(Fundele et al., 1989; Nagy et al., 1989; Paldi et al., 1989; Fundele et al., 1990; 
Barton et al., 1991; Mann et al., 1991). AG chimerism caused severe skeletal defects 
and often leads to lethality in chimeras (Mann et al., 1990). In contrast, PG chimeras 
were not lethal. However, cells derived from PG chimeras showed low proliferation 
rate, shorter cell cycle and increased senescence (Hernandez et al., 2003).  
Further analyses of AG and biparental ICM cell chimeras demonstrated that in AG/N 
chimeras the brain size was smaller and the body was larger. AG cells contribute 
extensively to hypothalamus and less to the cortex and striatum (Allen et al., 1995; 
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Keverne et al., 1996). On the contrary, PG and N ICM cell derived chimeric fetal 
brains were larger in size but the body of the chimeras was smaller. PG cells were 
found to contribute more to striatum and cortex, and less to the hypothalamus (Allen 
et al., 1995; Keverne et al., 1996). This biased developmental potential of AG and 
PG cells might be in part because of the lack or overexpression of imprinted genes, 
as these genes are preferentially expressed from only one parental allele. Moreover, 
this also points out towards contrasting impacts of imprinted genes in neural 
development (Allen et al., 1995; Keverne et al., 1996; Keverne 2001).  
Upon in vitro differentiation mouse uniparental ESCs are capable to produce 
derivatives of the three germ layers (Eckardt et al., 2008). Murine AG or PG ESCs 
can differentiate into engrafting hematopoietic stem cells and into neural stem cells 
(NSCs) (Eckardt et al., 2007; Lengerke et al., 2007; Dinger et al., 2008; Teramura et 
al., 2009). Uniparental mouse NSCs were further shown to differentiate into neural 
subtypes including dopaminergic neurons (Dinger et al., 2008; Teramura et al., 2009; 
Choi et al., 2010). Moreover, it was shown that the genetic correction strategy is 
applicable with PG ESCs for diseases associated with dominant alleles. This is 
possible by deriving PG ESCs from oocytes of a patient containing an allele that is 
free of the disease (Eckardt et al., 2011). 
 
4.2.4 hpESCs: features and prospective 
Cibelli et al., 2002 and Vrana et al., 2003 described the derivation of PG ESCs from 
non-human primates. The differentiation into the three germ layers and long-term 
engraftment of dopaminergic neurons in rats demonstrated that PG cells can be 
derived from primates which can further form functional neural cell types (Sanchez-
Pernaute et al., 2005). In 2007, four groups independently published reports on the 
derivation of hpESCs after artificial activation of unfertilized oocytes (Kim et al., 
2007; Lin et al., 2007; Mai et al., 2007; Revazova et al., 2007).  
The PG activation of an oocyte can be achieved using two different procedures 
(Rougier et al., 2001). In the first protocol, chemical activation of metaphase-2 
oocytes is performed before inhibition of the second polar body extrusion, which 
results in oocytes with a haploid genome (Lin et al., 2003; Lin et al., 2007; Revazova 
et al., 2008). The oocyte becomes diploid by spontaneous duplication of the genome 
by a phenomenon known as diploidization (Ito et al., 1991; Kim et al., 2007). Diploidy 
is maintained after the sister chromatids are segregated, which subsequently leads 
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to the formation of homozygous parthenotes (Fig. 3b). However, crossing over takes 
place during the prophase of the first meiotic division and the heterozygosity 
depends on the level of crossing over (Rougier et al., 2001). In the second method, 
the first polar body extrusion is inhibited, which results in a tetraploid oocyte (Kubiak 
et al., 1991; Kim et al., 2007). Diploidy is restored by exclusion of the second polar 
body at the end of oocyte maturation (Fig. 3C). Homologous chromosomes are not 
segregated when the first polar body extrusion is inhibited. The segregation of sister 
chromatids occurs after the exclusion of the second polar body. This leads to the 
derivation of a parthenote with genetic make-up identical to the oocyte (Kubiak et al., 
1991; Kim et al., 2007; Brevini et al., 2008). Together this indicates that the genetic 
constitution of PG embryos depends on the method employed for its activation (Fig. 
3) (Kim et al., 2007; Brevini et al., 2008). 
 
 
 
Fig. 3 Schematic representation of chromosomal changes occurring during 
normal or artificially induced oocyte maturation. (A) Genetic composition of in 
vitro fertilized embryos. (B) Homozygous parthenotes are formed by extrusion of the 
second polar body. Diploid status is reached by spontaneous duplication of the 
haploid genome (diploidization). (C) The first polar body is inhibited so extrusion of 
homologous chromosomes does not take place when activation is carried out. 
Diploidy is reached after the extrusion of the second polar body (adapted from Kim et 
al., 2007). 
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One of the major concerns before the application of hESCs in clinical studies is the 
immune response after transplantation into genetically unrelated recipients (Dawson 
et al., 2003; Ginis et al., 2003). The activation of the host’s immune system which 
leads to graft rejection is triggered by alloantigens or antigenic proteins present on 
the graft such as blood group antigens (ABO) and the major histocompatibility 
complex (MHC) proteins (known as human leukocyte antigens (HLA) in humans) 
(Tang et al., 2011). Matching donor and host HLA types is necessary to avoid a 
cytotoxic T-cell response in the host after transplantation (Drukker 2004; Utermohlen 
et al., 2009). But due to extensive polymorphism in HLA proteins the chance to find a 
donor-host HLA match is low (Mitalipov et al., 2009; Tang et al., 2011). Therefore, 
homozygosity in parthenotes represents an alternative strategy for deriving 
histocompatible pluripotent cells which reduces the immunogenicity of ESC-derived 
progeny. Pluripotent HLA homozygous hpESC lines have been derived from human 
oocytes (Kim et al., 2007; Lin et al., 2007; Revazova et al., 2008). Generation of 
hpESC lines that are homozygous for all three sets of HLA (A, B and DR) will 
increase the number of recipients a graft can match. These hpESC lines can be 
used for establishing HLA histocompatible ESC banks (Nakajima et al., 2007). 
Therefore, hpESCs are suggested to have a potential application in cell replacement 
therapies. Moreover, homozygous hpESCs were proposed to be advantageous for 
selecting cell lines with drug response, disease or cancer genes (Eckardt et al., 
2011). Additionally, in vitro hpESCs were shown to generate various cell lineages for 
example, mesenchymal stem cells, hepatocytes, pancreatic endocrine cells, retinal 
pigmented epithelial and neural progenitor cells (Harness et al., 2011; Chen et al., 
2012; Isaev et al., 2012; Turovets et al., 2012). On the other hand, homozygosity can 
cause amplification of an undesirable genetic component due to the loss of 
heterozygosity (Tang et al., 2011). 
 
4.3 Neural stem cells: properties and derivation from various sources 
Neural stem cells (NSCs) represent a self-renewable and multipotent adult stem cell 
type existing in the embryonic and adult mammalian central and peripheral nervous 
system (Kokovay et al., 2008; Goritz et al., 2012). In the developing brain various 
types of neuronal and glial cells originate from NSCs via the formation of 
intermediate precursors. Although less frequent, NSCs have regenerative 
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capabilities in the postnatal and adult brain where they generate neurons and glia 
(Ma et al., 2009; Goritz et al., 2012). Neurogenesis in vertebrate central nervous 
system starts with the induction of neuroectoderm and leads to the formation of a 
neural plate. Then the neural tube is formed with the invagination of the neural plate. 
These structures are made up by neuroepithelial progenitor cells (Gotz et al., 2005). 
During the maturation of the neural tube NSCs are present in the ventricular layer, 
closest to the lumen (Gotz et al., 2005; Goritz et al., 2012). 
In the adult mammalian brain, NSCs are present in two distinct regions, the dentate 
gyrus (DG) of the hippocampus (Eriksson et al., 1998) and the subventricular zone 
(SVZ) of the lateral ventricular wall (Johansson et al., 1999). NSCs exist in two 
developmentally different niches that maintain the self-renewal and regulate fate-
committed asymmetrical division of NSCs (Miller et al., 2009; Fuentealba et al., 
2012). 
NSCs can be isolated from the human embryonic and adult brains and cultured in 
vitro in defined media (Temple 2001). NSCs show self-renewal and multipotent 
characteristics in culture. Additionally, NSCs can be generated following in vitro 
differentiation of pluripotent hESCs similar to NSCs isolated from the human 
embryonic and adult brains.  
In vitro neural differentiation of pluripotent stem cells mimics the stages observed in 
normal embryonic brain development (Nishikawa et al., 2007). By using various 
differentiation protocols numerous groups reported the generation of a range of 
distinct neural precursor populations that are similar to the precursors present during 
various stages of a developing brain.  For instance, NSCs generated by Tropepe et 
al., 2001; Elkabetz et al., 2008; Chambers et al., 2009 show the molecular 
characteristics of neuroepithelial progenitors while NSCs derived by Koch et al., 
2009 resembles cells from the neural tube. Moreover, NSCs described by Bibel et al. 
2007 and Conti et al. 2005 were similar to fetal brain progenitor cells and adult brain 
NSCs respectively. 
There are three common approaches to promote neural induction of pluripotent stem 
cells (Dhara et al., 2008; Denham et al., 2009; Conti et al., 2010). The first is 
culturing cells in suspension to form aggregates of differentiated cells, called 
embryoid bodies, which in defined medium generate NSCs. The second procedure is 
to co-culture pluripotent stem cells on a feeder layer of stromal cells, such as PA6 or 
MS5 cell lines which induce neural differentiation as the factors required are 
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secreted by the feeder cells. Until now, the only approach that has been shown to 
induce neural differentiation in a defined manner is by directly inhibiting the BMP 
and/or SMAD signaling pathways. Using these neural differentiation approaches, 
various reports have shown that PG ESCs from different mammalian species 
including human are capable of differentiating into various neuroectodermal cell 
types, such as retinal pigment epithelium and NSCs (Harness et al., 2011; Isaev et 
al., 2012). 
 
4.4 Imprinting: mechanism and influence  
The majority of the mammalian genes are expressed from both the parentally 
inherited copies of the chromosomes. However, for some genes only one copy is 
expressed, depending on the parent of origin. These genes are termed imprinted 
genes, and the phenomenon is referred to as genomic imprinting (Surani 1994; 
Solter 1998). Imprinting is a temporal- and spatial-specific phenomenon. Imprinted 
genes are regulated by epigenetic mechanisms (Ferguson-Smith 2011). The term 
‘epigenetic’ refers to heritable changes in gene expression that are not accompanied 
by alteration of the DNA sequence (Wolffe et al., 1999). Epigenetic marks include 
changes in DNA methylation, covalent modifications of histone proteins causing 
conformational changes of the chromatin, and noncoding RNA (Smith et al., 2007). 
Various combinations of epigenetic modifications are necessary for imprinted gene 
regulation. In mammalian cells, DNA methylation of CpG dinucleotides is associated 
with a transcriptionally repressed state (Bird 2002). CpG dinucleotides are often 
found as CG-rich sequences called CpG-islands. CpG-islands are mostly 
differentially methylated at the promoters of imprinted genes, where the repressed 
allele is methylated and the active allele is unmethylated. These regions are known 
as differentially methylated regions (DMRs) (Pfeifer 2000; Ferguson-Smith et al., 
2001). Up till now, nearly 145 imprinted genes have been described in mice and 
approximately 80 in humans (catalogue of imprinting effects: http://igc.otago.ac.nz 
and the medical research council harwell genomic imprinting homepage: 
http://www.mousebook.org). Although isolated single imprinted genes have been 
identified in the human genome, a peculiar feature of imprinted genes is that they are 
frequently clustered in the genome (Spahn et al., 2003; Verona et al., 2003). Almost 
80% of the imprinted genes are clustered in various 1-5Kb sized chromosomal 
domains (Bartolomei et al., 2011; Ferguson-Smith 2011). Genes in clusters are 
25 
 
regulated by an element called imprinting control region (ICR), which is composed of 
DMRs (Pfeifer 2000; Spahn et al., 2003). ICRs regulate imprinted gene expression 
and epigenetic marks at many genes in a cluster, even those which are located 
several mega bases away (Verona et al., 2003; Lewis et al., 2006). 
Another characteristic of the clusters is that they mostly express noncoding RNAs 
(ncRNAs), which are expressed from the maternal allele (O'Neill 2005). The 
mechanism of regulation of imprinted clusters over long distances is currently 
explained by two models (Pauler et al., 2006; Wan et al., 2008). The first model 
involves ncRNA-mediated silencing of protein-coding genes in the same cluster 
(Peters et al., 2008). The maternal allele lacks ICR methylation therefore ncRNAs 
are expressed, which repress the genes present in the cluster; while genes are 
expressed from the paternal allele as the ncRNAs is repressed by the methylation of 
ICR. This model is demonstrated in the case of Kcnq1 and Igf2r ICRs (Pauler et al., 
2006; Peters et al., 2008; Mohammad et al., 2009). Another model involves the 
insulation of genes on one side of the ICR by CTCF (CCCTC binding insulator 
protein)-mediated blocking of enhancer elements as exemplified in the case of the 
H19/Igf2 locus (Thorvaldsen et al., 1998; Reik et al., 2000). There are several 
imprinted genes that demonstrate tissue- or cell- type specific imprinting (Hudson et 
al., 2011; Fedoriw et al., 2012). Placenta and brain are major sites for region-specific 
imprinting (Hudson et al., 2011; Fedoriw et al., 2012). For example, Igf2 is maternally 
silenced, except in the choroid plexus and leptomeninges of the brain where it is 
biallelically expressed (DeChiara et al., 1991). Another tissue type-specific imprinted 
gene, delta-like homologue 1 (Dlk1), shows absence of imprinting in the postnatal 
neurogenic niche whereas it is maternally silenced in all the other tissue types 
(Ferron et al., 2011). Ubiquitin protein ligase E3A (Ube3a) also shows tissue type-
specific imprinting: it is paternally imprinted only in the human brain (Rougeulle et al., 
1997; Vu et al., 1997), where it displays neuron-specific imprinting (Yamasaki et al., 
2003).  
 
4.4.1 Role of imprinting in the brain 
In a developing embryo imprinted gene are involved in growth and development, 
mainly in neurodevelopment (Keverne 2001; Wilkinson et al., 2007). Studies on 
chimeras obtained from AG or PG ESCs mixed with N embryos revealed that AG 
and PG cells localised to distinct regions of the brain. This provided evidence of 
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distinct roles of imprinted genes in the development of particular cell lineages in the 
brain (Keverne et al., 1996). Brain-specific imprinted genes interact with molecules of 
different signalling pathways that control the survival, patterning and differentiation of 
neural cells (Wilkinson et al., 2007). Imprinted genes also affect adult behavior for 
example the imprinted Grb10 gene regulates social behavior (Curley 2011; Garfield 
et al., 2011). Aberrations in imprinted gene function in human brain also lead to 
imprinting-related neurological disorders (Wilkins et al., 2011). Imprinting-related 
growth disorder Beckwith–Wiedemann is caused by abnormalities of the imprinted 
genes Igf2 and Kcnq1ot11, H19, Cdkn1c and Kcnq1 located on human chromosome 
11p15 (Weksberg et al., 2003; Abu-Amero et al., 2008). Prader–Willi and Angelman 
syndromes are also imprinting-related behavioural and neurodevelopmental 
disorders. These syndromes are caused by loss of function of imprinted genes 
Ube3a, Snrpn and Necdin situated on human chromosome 15q11-13 (Horsthemke 
et al., 2006).  
 
4.5 Aim and strategy 
The preferential localization of murine PG and AG ICM cells to distinct brain regions 
in chimeras (Keverne et al., 1996) Indicates distinct roles of the maternal and 
paternal genomes on brain development and function (Keverne 2001; Wilkinson et 
al., 2007; Curley 2011). Together with reports of centrosome amplification and 
chromosomal instability in PG cell lines derived from mammals including humans 
(Brevini et al., 2012), this could indicate a restricted neurogenic competency of 
hpESCs. The differentiation potential of hpESCs, particularly their potential for 
neurogenesis and differentiation into functional neuronal subtypes, is currently not 
analysed in detail. Therefore here I investigated the in vitro differentiation capability 
of hpESCs into NSCs and further into neural subtypes including midbrain TH-positive 
neurons and motoneurons. In parallel I examined the functional aspects and the 
imprinting status of hpESCs and hpNSCs.  
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5. RESULTS 
 
5.1 Optimization of hpESCs culture conditions  
hpESCs (cell lines: LLC6P, LLC9P) were grown on mitomycin C-inactivated human 
foreskin fibroblast (HFF) or feeder free on matrigel (Fig. 4A). hpESCs were reported 
to have an improved propagation upon addition of umbilical cord blood serum (UBS) 
to the culture medium (Revazova et al., 2007). Furthermore, it was reported that 
hypoxic culturing allows long-term propagation of hESCs without spontaneous 
differentiation (Prasad et al., 2009; Lim et al., 2011). To optimise culture conditions, 
hpESCs were propagated under 4% or 20 % oxygen and in different serum 
conditions. The following conditions were tested: 10% knockout serum replacement 
(KSR) plus 10% UBS, 10% KSR plus 5% UBS and 20% KSR, respectively. hpESCs 
propagated under different serum and oxygen concentrations showed minor 
variations in cell numbers (Fig. 4B). hpESCs grown under 4% oxygen and 20% KSR 
or under 20% oxygen and 20% KSR stained positive for alkaline phosphatase (AP) 
activity (Fig. 4C). In addition, hpESCs homogenously expressed pluripotency marker 
Oct4 and Sox2 and showed absence of expression of the differentiation marker 
SSEA1 (stage specific embryonic antigen 1) (Lin et al., 2007; Mai et al., 2007; 
Revazova et al., 2007). All together this showed that hpESCs could be propagated in 
KSR under normal oxygen concentrations with no major change in cell numbers, or 
AP activity cells propagated with KSR and under 20% oxygen expressed 
pluripotency markers and lacked expression of differentiation associated marker. 
 
 
28 
 
 
 
Fig. 4 Optimization of hpESCs culture conditions. (A) Shown are phase-contrast 
images of hpESC cell lines LLC6P (left), LLC9P (middle). Cells grown on mitomycin 
C-inactivated HFF or matrigel (right, cell lines LLC9P). (B) Graph represents cell 
counts of hpESCs which were propagated under 4% or 20 % oxygen conditions as 
well as on 10% KSR plus 10% UBS, 10% KSR plus 5% UBS or 20% KSR. (C) 
Images of alkaline phosphatase staining of hpESCs grown under 4% oxygen and 
20% KSR (top image) or 20% oxygen and 20% KSR (lower image) are shown. (D) 
Confocal images of hpESCs (LLC9P) co-immunostained with Oct4- and SSEA1- 
specific antibodies. Nuclei were co-stained with DAPI. Scale bars: 50 µm; n=3. 
 
5.2 hpESC-derived teratoma in NOD-SCID mice 
To assess the ability of hpESCs (LLC9P) to form derivatives of the three germ 
layers, teratomas were generated by injection of hpESCs into a cryolesioned brain of 
immunodeficient NOD-SCID mice. Transplantations were performed one week after 
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lesion induction to avoid excessive loss of the transplanted cells due to acute post-
injury inflammation (Siren et al., 2006). Two recipients, each were transplanted per 
dose with 2x104, 5x104 or 10x104 cells. Transplantation of undifferentiated hpESCs 
resulted in the formation of teratomas three months after injection in 2 out of 6 
transplanted brains. Animals transplanted with 5x104 or 10x104 cells developed 
teratomas. Hematoxylin and eosin staining of transplanted brain sections 
demonstrated the presence of organized structures, including smooth muscle, 
cartilage, and blood representing mesodermal germ layer and ciliated epithelium, 
respiratory epithelium, as well as gastrointestinal lining cells of endodermal origin 
(Fig. 5A). Donor origin of teratomas was verified by positive immunostaining of 
teratoma with human nuclei-specific antibody (HNu) (Fig. 5B). This data showed that 
hpESCs are capable of forming teratomas that comprises cells of various cell types. 
 
 
 
Fig. 5 hpESC-derived teratoma. (A) Depicted are bright field images of 
haematoxylin and eosin stainings of teratomas derived from transplantations of 
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hpESCs into brain-injured NOD-SCID mice. On the basis of morphology we 
observed muscle (upper left), cartilage (upper middle), blood (upper right), ciliated 
epithelium (lower left), respiratory epithelium (lower middle) and gastro-intestinal 
lining cells (arrows indicate the cell types). Scale bars: 100 µm (B) Representative 
confocal images of hpESC-derived teratomas immunostained for human nuclei-
specific antibody (HNu) and DAPI. Scale bars: 100 µm; n=2. 
 
Fig. 6 hpNSCs generated from hpESCs (cell line LLC9P). Images illustrate critical 
stages of in vitro neural differentiation of hpESCs towards hpNSCs. Starting from 
hpESCs grown on HFF (A), to hpESC-derived floating embryoid bodies (B), followed 
by attached embryoid bodies (C, arrows indicate a rosette-like pattern) then to 
floating neurospheres (D), and finally to hpNSCs (E). Scale bars: left panel: 0.5 mm; 
other panels: 0.25 mm; n=3. 
 
5.3 Neural differentiation of hpESCs 
To evaluate the in vitro neural differentiation potential, hpESCs (LLC9P and LLC6P) 
were neuralized using a multi-step protocol that induces the differentiation of hESCs 
into NSCs (Koch et al., 2009). Upon differentiation of hpESCs neural rosettes 
appeared after attaching 4-day-old embryoid bodies on polyornithine/laminin-coated 
dishes (Fig. 6A&B). 10 to 12 days later rosettes formed 3-dimensional structures 
(Fig. 6C). These structures were detached from the culture dishes and grown as 
floating neurospheres for 1 to 2 days (Fig. 6D). Next, neurospheres were dissociated 
to form single cells and plated as a monolayer under defined culture conditions on 
polyornithine/laminin-coated dishes (Fig. 6E). These conditions yielded NSC-like 
cells with homogeneous morphology. The NSC identity was confirmed by gene 
expression analysis, that revealed up-regulation of NSC markers Sox1, Nestin, 
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Pax6, and Musashi1, loss of expression of the pluripotency markers Oct4 or Nanog 
(Fig. 7A) and absence of activation of the markers for non-neural lineages like neural 
crest (Snai2, FoxD3) and mesoderm (Acta1) (Fig. 7B).  Further hpESC-derived 
neural stem cells (hpNSCs) were stained positive for NSC markers Nestin, Sox1, 
Sox2 and Vimentin (Fig. 8). The NSC marker expression in hpNSCs was ubiquitous 
and not limited to subsets of cells. Similar results were obtained with hpESC cell line 
LLC6P (Fig. 9). Upon differentiation, two 10 cm2 culture dishes of LLC9P hpESCs 
yielded a mean of 29 (±3.5) million hpNSCs whereas, LLC6P hpESCs generated 
11.8 (±1.7) million cells. Together these results showed that hpESCs can 
differentiate into hpNSCs that expressed NSC-specific markers and lacked gene 
expression of pluripotency and non-neural lineage markers. 
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Fig. 7 Expression analyses of pluripotency, NSC and neural crest cell markers 
(cell line LLC9P). (A) Representative semi-quantitative RT-PCR analyses for the 
expression of pluripotency markers Oct4, Nanog and neural stem cell markers Sox1, 
Nestin, Pax6 and Mushashi1 (MS1) in hESCs, hNSCs, hpESCs, and hpNSCs are 
shown. GAPDH is the house-keeping control. (B) Shown are expression analyses of 
neural crest cell markers Snai2 and FoxD3 and mesodermal marker Acta1 in hESCs, 
hNSCs, hpESCs, and hpNSCs at passages 5, 10 and 15 by RT-PCR. Human PG 
neural crest stem cells (hpNCSCs), human fetal brain (hFB) and human adipose 
tissue-derived mesenchymal stromal cells (hMSCs) are shown as controls.  
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Fig. 8 Immunophenotypic characterization of hpNSCs (cell line LLC9P). Shown 
are representative confocal images of hpNSCs immunostained for neural stem cell 
markers Nestin, Sox1, Sox2, and Vimentin. Cells were co-stained with DAPI. Scale 
bars: 50 µm; n=3. 
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Fig. 9 hpESC-derived hpNSCs from LLC6P cell line. (A) Images depict stages of 
in vitro neural differentiation of hpESC towards hpNSCs. Scale bars, left panel: 0.5 
mm; other panels: 0.25 mm. (B) Shown are representative RT-PCR analyses for the 
expression of Oct4, Nanog, Sox1, Nestin, Pax6 and MS1 in hESCs, hNSCs, hpESCs 
and hpNSCs. Also represented are expression analyses of neural crest cell markers 
Snai2 and FoxD3 and the mesodermal marker Acta1 in hESCs, hNSCs, hpESCs, 
and hpNSCs (passages 5, 10). hpNCSCs, hFB and hMSCs are shown as controls. 
(C) Images exhibit immunostaining of hpNSC cultures with antibodies specific for 
Nestin, Sox1, Sox2, and Vimentin. Images were taken by confocal microscopy. 
Scale bars: 50 µm; n=3. 
 
5.4 Expression of mitotic checkpoint and extracellular matrix genes in hpESCs   
A recent report demonstrated abnormal levels of gene expression of molecules 
related to spindle formation in hpESCs compared to hESCs (Brevini et al., 2009). 
Particularly MAD1, MAX and SIN3 showed higher levels of gene expression, 
indicating deregulation in the MAD1-dependent pathway. Further, low transcription 
levels of CENP-E, TTK and Aurora A kinase, may point towards aberration at 
different spindle check points (Brevini et al., 2009). Together, this may indicate that 
alteration of proliferation mechanisms occurs in hpESCs, probably related to the 
uniparental origin (Brevini et al., 2009). Therefore, the expression levels of specific 
mitotic spindle check-point proteins was assessed, in PG (LLC6P and LLC9P) 
compared to conventional ESCs (I3 and H9). As shown in (Fig 10A) variation in gene 
expression level was detected. This dissimilarity was apparent not only between 
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hpESCs and hESCs cells but also between individual ESC lines independent of PG 
or N origin.  
In addition, differences in differentiation potential between hpESCs and hESCs were 
reported. This might be due to reduced levels of extracellular matrix (ECM) 
transcripts in hpESCs (Harness et al., 2011). A comparison of expression levels of 
the ECM transcripts in hpESCs and hESCs showed that, LLC6P hpESCs had lower 
ECM gene expression compared to LLC9P cells and hESCs (Fig. 10B).  
 
Fig. 10 Analyses of mitotic checkpoint and extracellular matrix gene 
expression by quantitative RT-PCR. (A) RNA expression of spindle formation- and 
chromosome segregation-related genes were analyzed in hpESCs compared to 
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hESCs (I3 and H9) ESCs, respectively. The genes analyzed were MAD1, BUB1, 
CENPE, TTK kinase, aurora A kinase, MAX and SIN3. (B) Representative 
expression analyses of extracellular matrix molecules in hpESCs compared to 
hESCs. The genes analyzed were MMP1, MMP7, COL11A1, NCAM1, VCAM1 and 
ITGA8. Expression levels of hESCs were set to 1. Fold change was calculated by 
the 2-ΔΔCt method. The housekeeping gene GAPDH was used as a reference. n=3, * 
p<0.05, ** p<0.01, *** p<0.001 by Student’s t-test. 
 
5.5 Terminal differentiation of hpESCs-derived hpNSCs  
To study the in vitro differentiation potential of hpNSCs into neural sub-types, 
hpNSCs were differentiated by growth factor (FGF-2 and EGF) withdrawal (Fig 11A). 
28 days differentiated hpNSC-derived cells expressed transcripts of Tuj-1 (class III 
beta-tubulin, neurons), GFAP (glial fibrillary acidic protein, astrocytes), S100B (S100 
calcium binding protein B, astrocytes), Olig2 (oligodendrocyte transcription factor 2, 
oligodendrocyte), (Fig. 11B). Expression levels were similar to RNA isolated from a 
human fetal brain isolate, while these transcripts were not detected in 
undifferentiated hpESCs. hpNSC-derived cells immunostained positive for neural 
sub-types markers NeuN (neuronal nuclei), neuron-specific Tuj-1, MAP2 
(microtubule associated protein 2), astrocyte marker GFAP and oligodendrocyte 
marker (O4) (Fig. 11C). hpNSC-derived neurons also stained positive for expression 
of presynaptic vesicle protein Synapsin-1, axonal marker Tau and MAP2. 
Furthermore, Tuj1/DAPI positive cells co-expressed the neurotransmitter GABA (γ-
aminobutyric acid) (Fig. 11C). Overall, hpNSCs favor neuronal differentiation (61 ± 
1.6% of cells), specifically GABAnergic neurons (95 ± 1.3%), whereas glial cells 
were less frequently detectable (17 ± 0.3% of cells). On the other hand, 
oligodendrocytes were only detectable after 6 weeks of differentiation (2 ± 0.3% of 
cells) (Fig. 11D). Similar cell percentages of neuronal and astroglial differentiation 
were observed for the hpESC line LLC6P, with the exception that O4-positive cells 
were not detected (Fig. 11D). Together this shows that hpESC-derived hpNSCs can 
differentiate in vitro into cells with immunophenotypic features of neurons, astrocytes 
and oligodendrocytes. hpNSCs favored neuronal differentiation particularly 
GABAnergic neurons. hpNSC-derived neurons also express presynaptic vesicle 
protein Synapsin-1 which indicates that these neurons may be capable of forming a 
synapse. 
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Fig. 11 Terminal differentiation of hpNSCs into neural and glial cell types (cell 
line LLC9P). (A) Schematic representation of in vitro neural differentiation of 
hpNSCs towards neural subtypes (scheme adapted from Koch et al., 2007). (B) 
Shown are semi-quantitative RT-PCR analyses of neural and glial markers Tuj1, 
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GFAP, S100B, Olig2 in hpESCs, hpESC-derived neuronal and glial cells (hp neural 
cells) and hFB. GAPDH was used as house keeping control. (C) Images show 
immunostaining of hp neural cells with neural subtype-specific antibodies: Tuj1, 
NeuN, Map2, GFAP, O4, Synapsin1/Map2/Tau (insert shows higher magnification) 
and Tuj1/GABA. Cells were counterstained with DAPI. Images were taken by a 
confocal microscope. (D) Neural subtypes: NeuN, Tuj1, Map2, GFAP and O4 
percentages are given for cell lines LLC9P and LLC6P. Neuronal or glial marker- and 
DAPI-positive cells were counted to determine percentages. ImageJ software was 
used for counting. Scale bars: 50 µm; n> 3. 
 
5.6 Region-specific differentiation of hpNSCs 
Induction of regional phenotypes such as dopaminergic neurons and motoneurons 
was utilized to assess the responsiveness of hpNSCs towards instructive 
regionalization cues.  
For induction of dopaminergic neurons hpNSCs were cultured in the presence of 
sonic hedgehog (SHH) and FGF8b for 8 days as described (Perrier et al. 2004).  
Then cells were cultured for three weeks in the presence of BDNF and GDNF (Fig. 
12A). Midbrain-specific transcripts Nurr1 (nuclear receptor related 1 protein), En1 
(engrailed homeobox 1) and Pax2 (paired box gene 2) were expressed in human 
fetal brain isolate and hpNSC-derived cells (after 28 days of differentiation) and were 
absent in undifferentiated hpESCs (Fig. 12B). Immunocytochemical staining 
revealed expression of midbrain markers En1 and Pitx3 (paired-like homeodomain 
3), which are transcription factors required for differentiation and survival of midbrain 
dopaminergic neurons and for TH (dopamine biogenesis) (Fig. 12B). Three 
independent differentiations generated 79.8 ± 3.2% En1, 10.8 ± 0.6% Pitx3 and 13.3 
± 1.6% TH positive cells (Fig. 12B). 
To explore the potential induction of motoneurons from hpNSCs (Li et al. 2005), cells 
were exposed to 1 µM retinoic acid and SHH alternatively with or without FGF2 and 
EGF for 6 days each. Then cells were cultured with BDNF and GDNF for 14 days 
(Fig. 13A). After 28 days of differentiation, transcripts of the motoneuron markers 
HoxA1 and HoxA2 were detectable in differentiated cultures but not in 
undifferentiated hpESCs (Fig. 13B). Correspondingly, immunostaining revealed 
nuclear expression of Isl1 (ISL LIM homeobox1, marker for motoneuron progenitors), 
Nkx2.2 (NK2 homeobox 2, ventral brain marker), HB9 (motor neuron and pancreas 
homeobox 1, motoneuron marker) and MAP2 (neuronal marker) (Fig. 13B). In 
aggregate hpNSCs generated 80.1 ± 3% Isl1, 70.9 ± 2.6% Nkx2.2 and 79.1 ± 2.9% 
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HB9 positive cells (Fig. 13B). In summary, the data indicated that hpNSCs are 
responsive to instructive regionalization cues and hpNSCs can differentiate into cells 
that express dopaminergic and motoneuron markers. Neuronal cells that express 
dopaminergic or motoneuron markers were also observed upon differentiation of 
hpESC line LLC6P. Altogether, this set of data showed that hpNSCs have the 
capability to be modulated towards different regional phenotypes such as 
dopaminergic neurons and motoneurons. 
 
 
 
Fig. 12 Differentiation of hpNSCs towards dopaminergic neurons (A) Schematic 
representation of in vitro neural differentiation of hpESCs (LLC9P) towards 
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dopaminergic neurons and into motoneuron fates (scheme adapted from Koch et al., 
2007). (B) Representative analyses for the expression of midbrain transcripts Nurr1, 
En1 and Pax2 by RT-PCR. Images exhibit immunostaining with antibodies specific 
for En1, Pitx3 and TH. Cells were co-stained with DAPI. Percentages of DAPI and 
En1, Pitx3 or TH positive cells are indicated (LLC9P and LLC6P). Scale bars: 50 µm; 
n=3 
 
 
 
Fig. 13 Motoneurons generated from hpNSCs (LLC9P).  
(A) Schematic representation of in vitro neural differentiation of hpESCs (LLC9P) 
towards motoneurons (scheme adapted from Koch et al., 2007). (B) Analyzed are 
the expression of HoxA1 and HoxA2 by RT-PCR. Corresponding images of 
41 
 
immunostainings for the expression of motoneuron markers: Isl1, Nkx2.2 and HB9. 
Nuclei are counterstained with DAPI. Given are the percentage cell counts of Isl1, 
Nkx2.2 and HB9- and DAPI-positive cells for LLC9P and LLC6P. Scale bars: 50 µm; 
n=3. 
 
5.7 Electrophysiological analyses of hpESCs-derived neurons  
Next it was investigated whether hpNSCs-derived neurons (PG neurons) can 
functionally mature in vitro. Patch-clamping was performed on the PG neurons to 
assess their electrophysiological properties. As shown in Fig. 14A typical neuronal 
Na+/K+ currents in voltage clamp mode (VC stimulation pattern: -80 mV to +55 mV, 
step size 15 mV, stimulation time 20 ms) were exhibited by PG neurons. Multiple 
action potentials with a maximum frequency of 30 Hz were derived with depolarizing 
step current injections over a 500 ms time period (Fig. 14B). PG neurons exhibited a 
typical neuron-like current pattern when maximum in- and outward currents were 
plotted against the corresponding stimulation voltage (Fig. 14C). Further, PG 
neurons were responsive to pharmacological channel blockers of sodium 
(tetrodotoxin) and potassium (tetraethylammonium) (Fig. 14D). These results show 
that electrophysiological properties of PG neurons at 28 days of differentiation were 
comparable to those reported in literature for human in vitro induced neuronal cells 
(Table 1). 
 
 Table 1. Electrophysiological characteristics of PG neurons 
 
 
      mean      SD  N 
resting membrane potential (mV)     - 32.50 ± 7.27 14 
membrane capacitance (pF) 9.31 ± 3.88 14 
series resistance (M) 7.83 ± 2.91 14 
number of  induced action 
potentials 
12 out of 12 
recordings   
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Fig. 14 Electrophysiology of PG neurons.  Electrophysiological studies (patch-
clamping) were performed on PG neurons (LLC9P) differentiated for 28 days. (A)  
Shown are representative current traces of PG neurons in whole cell configuration in 
response towards step depolarization (insert: sodium stimulation). Stimulus in VC 
mode was provided by stepwise increment of membrane potential (-80mV to +55mV, 
step size 15mV) (B) Membrane potential traces in response to step depolarization by 
current injection in current clamp mode; depolarization - black line, hyperpolarization 
- grey line. (C) Current (I) / voltage (V) curves from VC-stimulation. The maximum 
and the minimum measured currents were used to plot the graph of stimulation 
potential [mV] (current normalized to cell size [pA/pF]). (D) The graph shows I/V 
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curves of VC-stimulation before and after treatment of PG neurons with the Na+ 
channel blockers tetrodotoxin (TTX) or K+ channel blocker tetraethylamonium (TEA). 
The highest and the lowest measured currents were plotted against each other to 
produce the stimulation potential [mV] graph (current was normalized to cell size 
[pA/pF]). n=3.  
 
5.8 Analysis of differentially methylated regions of imprinted brain genes by 
bisulfate sequencing 
Alterations of genomic imprinting in human embryos can contribute to the 
development of disorders linked to maternally or paternally expressed genes 
(Gabriel et al., 1998). hpESCs require a detailed imprinting analysis because of the 
possible influence on differentiation and the functionality of differentiated progeny. 
Expression of imprinted genes is achieved by parent-of-origin-specific epigenetic 
modifications mainly by DNA methylation of ICR (Ferguson-Smith, 2011). Therefore 
to assess the methylation status of ICR during neural differentiation CpG islands of 
two differentially methylated regions (DMR) were analyzed in hpESCs and hpNSCs 
(PG cells) in comparison to hESCs and hNSCs (N cells). 24 CpGs of KvDMR1 were 
analyzed by bisulfate sequencing. KvDMR1 controls the imprinting of one paternally 
expressed long-noncoding RNA, Kcnq1ot1, and eight maternally expressed protein-
coding genes, including Cdkn1c (cyclin-dependent kinase inhibitor 1c), Kcnq1 
(potassium voltage-gated channel, KQT-like subfamily, member 1) (Verona et al., 
2003). The Kcnq1ot1 transcription start site (TSS) is located within the KvDMR1. 
When methylated on the maternal allele, Kcnq1ot1 is silent (Mancini-DiNardo et al., 
2003). On the paternal allele, the KvDMR is unmethylated and Kcnq1ot1 is 
transcribed which represses the expression of eight maternally imprinted genes 
(Fitzpatrick et al., 2002). As shown in Fig. 15A, 50% methylation at the CpGs of 
KvDMR1 in N cells indicating biparental origin was observed. As anticipated from PG 
cells, CpGs of KvDMR1 in hpESCs and hpNSCs were hypermethylated. Quantitative 
RT-PCR analysis revealed lack of Kcnq1ot1 expression and higher expression of 
Kcnq1 but not Cdkn1c in PG compared to N cells (Fig 15B & 16B).  
H19 is solely expressed from the maternal allele (Zhang et al., 1992) while Igf2 is 
expressed only from the paternal allele (Giannoukakis et al., 1993). The two genes 
share an enhancer region that is located downstream of H19 (Leighton et al., 1995) 
The ICR of H19 is a boundary element, controlled by DNA methylation (Bell et al., 
2000, Hark et al., 2000, Szabo et al., 2000). The CTCF protein (transcriptional 
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repressor) binds to the unmethylated maternal ICR, which prevents the promoters 
located in the Igf2 gene from interacting with the enhancers resulting in the 
transcriptional silencing of Igf2 (Bell et al., 2000, Hark et al., 2000, Szabo et al., 
2000, Kanduri et al., 2000). The methylated paternal ICR prevents the binding of 
CTCF, which allows the enhancers to contact the promoters of the paternal Igf2 and 
the gene is transcribed (Hark et al., 2000, Schoenherr et al., 2002). Bisulfite 
sequencing showed that most of the H19 DMR1 CpGs were methylated in N cells 
while PG cells showed partial or complete absence of methylation of H19 DMR1 
CpGs (Fig 15C). Gene expression analysis revealed absence of Igf2 expression and 
over-expression of H19 in PG compared to N cells (Fig. 15D & 16B).  
Together these results show that imprinted genes in hpESCs and hpNSCs upon 
differentiation maintained imprinting-specific DNA-methylation and maternal-specific 
gene expression.  
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Fig. 15 Analysis of the methylation status of differentially methylated regions 
(DMRs) and expression analysis of imprinted genes. Bisulfite sequencing and 
imprinted gene expression analyses in hESCs, hNSCs, (I3) and in hpESCs, hpNSCs 
(LLC9P), respectively are shown. (A) Shown are the location of KvDMR1 and the 
transcriptional start sites of Cdkn1c, Kcnq1ot1 and Kcnq1 as line diagram (maternal 
allele). Data exhibits bisulfite sequencing results of KvDMR1 (position: 66531-66801) 
in N and PG cells. Black boxes: methylated CpGs; grey boxes: unmethylated CpGs; 
white boxes: not analyzed. Percentages of CpG methylation are indicated. (B) 
Representation of RT-PCR analyses of imprinted genes Kcnq1ot1, Kcnq1 and 
Cdkn1c in PG and N cells. The relative expression represents the fold change of 
gene expression in PG compared to N cells, respectively. Fold change was 
calculated by the 2-ΔΔCt method. GAPDH was used as a reference gene. Expression 
levels of N cells were set to 1. n=3. (C) The line diagram depicts the location of 
DMR1 (position: 66531-66801) and the transcriptional start sites of Igf2 and H19 
(maternal allele). Also included are bisulfite sequencing analyses of DMR1 in PG 
and N cells. (D) Shown are Igf2- and H19-specific gene expression analyses on N 
and PG cells. n=3, * p<0.05, ** p<0.01, *** p<0.001. 
 
5.9 Analysis of imprinted brain genes by quantitative real-time PCR 
The expression level of imprinted brain genes was analyzed by quantitative RT-PCR. 
As shown in Fig. 16 the paternally expressed Snrpn and Nnat genes were not 
detected or were poorly expressed while the maternal expressed Gtl2, Dlx5 and 
Kcnk9 genes exhibited higher levels of expression in both hpESCs and hpNSCs 
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compared to hESCs and hNSCs, respectively. However, Igf2r expression was 
elevated only in hpESCs but not in hpNSCs. These results indicate that the analyzed 
imprinted genes maintain their parent-of origin-specific gene expression bias during 
neural differentiation in hpESC lines LLC6P and LLC9P. 
 
 
Fig. 16 Analyses of imprinted gene expression in hpESCs and hpNSCs 
(LLC9P). (A) Relative expression levels of imprinted genes in hpESCs compared to 
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hESCs (I3) are given. Fold change was calculated by the 2-ΔΔCt method. Expression 
levels of hESCs were set to 1. In brain Snrpn and Nnat are preferentially paternally 
expressed, and Gtl2, Dlx5, Ube3a and Igf2r are preferentially maternally expressed. 
(B) Shown are expression levels of imprinted genes: Snrpn, Nnat, Gtl2, Dlx5, Ube3a 
and Igf2r in hpNSCs compared to hNSCs. Fold change was calculated by the 2-ΔΔCt 
method. Expression levels of hNSCs were set to 1. n=3, * p<0.05, ** p<0.01, *** 
p<0.001. 
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6. DISCUSSION  
The aim of this study was to define the capability of hpESCs to differentiate towards 
neural cell lineages in vitro. In summary, the results demonstrated that despite the 
lack of paternal genome, hpESCs generated proliferating NSCs that were capable to 
differentiate into neural and glial cell types. The hpESC-derived neurons were 
physiologically functional. Furthermore after neural differentiation PG cells 
maintained allele-specific expression of imprinted genes.  
 
6.1 Maintenance of hpESCs cultures 
ESCs, which are derived from the ICM of blastocyst stage embryos, have the ability 
to self-renew. The other defining characteristic of ESCs is pluripotency—that is the 
ability to differentiate into any cell type of the adult body (Thomson et al., 1998). 
Earlier reports suggested that hpESCs propagation was improved by the addition of 
human UBS to the culture medium (Revazova et al., 2007). However, results 
gathered in this thesis indicated that human UBS supplementation had no effect on 
hpESCs propagation. hpESCs were able to self-renew in medium containing 
synthetic KSR medium. Similar to previous reports hpESCs cultured with KSR 
maintained the expression of pluripotency markers (Lin et al., 2007; Mai et al., 2007; 
Revazova et al., 2007). Furthermore, KSR-cultured hpESCs were able to generate 
teratomas comprising of three germ layers when transplanted into immunodeficient 
mice (Lin et al., 2007; Mai et al., 2007; Revazova et al., 2007). This verifies that 
hpESCs are pluripotent and have the potential to differentiate into the various germ 
layers in vivo. 
 
6.2 Neural differentiation of hpESCs 
The results shown here also confirmed that hpESCs can differentiate into hpNSCs. 
Similar to previous reports on conventional ESC-derived NSCs, expression of 
pluripotent cell-specific transcription factors was absent in hpNSCs (Conti et al., 
2005; Koch et al., 2009). hpNSCs exhibited appropriate expression of NSC-specific 
genes and the absence of neural crest (Snai2, FoxD3) and mesodermal marker 
(Acta1). A comparative study on neural differentiation potential of PG and N ESCs 
indicated that hpESCs yielded low quantities and impaired maturation of neural cells 
mainly due to reduced cell-cell interaction in hpESCs (Harness et al., 2011). The 
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protocol used by Harness et al., 2011 for neural differentiation included a 
neurosphere formation step, which depends greatly on cell-cell interactions. They 
concluded that the differences in cell-cell interaction were possibly due to variation in 
gene expression profile of ECM molecules in PG compared to N ESCs. This was 
discussed to contribute to decreased neurosphere formation capability of hpESCs. 
Although one of the hpESC line (LLC6P) analyzed in this thesis was also studied by 
Harness et al., 2011, the results obtained here are contradictory. A possible reason 
could be that in this thesis an alternative differentiation procedure was followed, 
which was optimized for producing standardized NSCs with reduced spontaneous 
differentiation and minimized restriction of lineage-specific differentiation (Koch et al., 
2009). The different culture systems can be an explanation for the contrasting 
results. In addition, I noticed that hpNSCs yields varied between the two hpESC lines 
(LLC6P and LLC9P). Harness et al., 2011 observed that hpESCs showed low 
expression levels of the early neuroblast marker NCAM1 compared to hESCs. On 
the contrary, I observed high yields of hpNSCs from LLC9P cell line, which could be 
explained by the profound expression of NCAM1 in these cells (Knoth et al., 2010). 
Hence the neurogenic capability of hpESC lines was paralleled by the dissimilarity in 
NCAM1 gene expression that indicated cell-to-cell heterogeneity as reported earlier 
between independent hESC lines (Allegrucci et al., 2007; Osafune et al., 2008; Pal 
et al., 2009; Tavakoli et al., 2009; Lappalainen et al., 2010). I also observed 
variations in gene expression levels of molecules related to spindle formation and 
mitotic checkpoint genes in PG in comparison to N ESCs as well as between the two 
hpESC lines. These variations were likely due to differences between the cell lines 
(Allegrucci et al., 2007; Osafune et al., 2008; Pal et al., 2009; Tavakoli et al., 2009; 
Lappalainen et al., 2010). Another reason might be the genetic imbalance observed 
in uniparental ESCs (Brevini et al., 2009).  
 
6.3 hpNSC-derived neural subtypes 
The present study indicated that hpNSCs were capable of generating mature 
neurons and glia. The stem cell status of hpNSCs was proven by the stable neuro- 
and gliogenic differentiation potential through various passages. hpNSCs responded 
to cues which directed them to differentiate towards ventral midbrain dopaminergic 
and ventral spinal cord motoneurons. This showed that hpNSCs were receptive to 
growth factors responsible for directing differentiation of NSCs into regional 
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phenotypes such as midbrain TH- neurons and HB9-positive neurons (Perrier et al., 
2004; Li et al., 2005). I further showed that upon exposure to optimized 
differentiation conditions PG neurons generated action potentials and exhibited 
electrophysiological membrane properties similar to newly formed or hESC-derived 
neurons (Conti et al., 2005; Koch et al., 2009). Studying the PG neurons by 
immunocytochemical analyses revealed high frequencies of GABAergic neurons. 
Preferential differentiation into GABAergic neurons is a well-known phenomenon in 
NSCs, regardless of whether they are derived from cortex, striatum or from hESCs, 
cultured in monolayer or in aggregation (Conti et al., 2005; Zhang 2006; Koch et al., 
2009). The reason of this bias is not known. A possible explanation is that during 
NSCs expansion the presence of growth factors can lead to quick loss of the 
proficiency of NSCs to generate site-specific neuronal subtypes (Conti et al., 2010). 
Nonetheless, monolayer culture results in the disruption of the three-dimensional 
tissue structure and modification of the extracellular environment that probably alters 
the factors responsible for the generation of neuronal subtypes. 
Altogether this shows that EGF- and FGF2-dependent monolayered hpNSCs retain 
multipotentiality and neurogenic efficiency after in vitro expansion and show 
competence to efficiently generate electrophysiologically active PG neurons when 
exposed to differentiation conditions. The unperturbed neural differentiation potential 
of hpESCs is consistent with earlier reports of successful murine AG ESC-derived 
neurogenesis (Mann et al., 1991; Dinger et al., 2008; Teramura et al., 2009). The 
analyses indicate that uniparental ESCs are less restricted in their neural 
developmental potential than predicted from in vivo studies (Mann et al., 1990; 
Keverne et al., 1996). However, sophisticated animal transplant models are needed 
to assess the broader neural differentiation potential of hpESCs. 
 
6.4 Imprinting in hpESCs and hpNSCs 
Genomic imprinting is based on an epigenetic mechanism of gene regulation which 
results in parent-of-origin–dependent monoallelic gene expression (Bartolomei et al., 
2011). A genome-wide analysis of imprinted genes in embryonic and adult mouse 
brains demonstrated that nearly 1300 loci show parent-of-origin-specific expression 
(Gregg et al., 2010).  However, independent repetitions of this genome-wide analysis 
suggested that a large number of false-positive imprinted genes were reported 
mainly due to discrepancies in the analyses and experimental methodology 
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(DeVeale et al., 2012). Nevertheless, this high-throughput transcriptome sequencing 
estimated the number of imprinted brain genes, which was comparable to the known 
number of imprinted genes in the brain (DeVeale et al., 2012; Kelsey et al., 2012). 
Moreover, previous reports using similar global screen approaches reported only a 
few novel imprinted genes (Babak et al., 2008; Wang et al., 2008). 
Imprinted genes expressed in the brain are associated with a variety of neural 
functions including feeding, behavior and biochemical pathways governing 
metabolism and cell adhesion (Wilkinson et al., 2007; Curley 2011). The in vitro 
neural differentiation of hESCs is astonishing, taking into consideration the large 
number of imprinted genes expressed in the brain and the contribution of imprinted 
genes in brain development (Keverne 2001; Wilkinson et al., 2007; Curley 2011). We 
observed in PG cells that CpG methylation in the KvDMR was consistent with PG 
origin. The expression level of paternally expressed Kcnq1ot1 was reduced and 
maternally expressed Kcnq1 was up regulated in PG cells compared to N cells. 
However, maternally expressed Cdkn1c transcripts were only upregulated in one PG 
cell line (LLC6P) in comparison to N cells. The reason could be cell-to-cell 
heterogeneity as reported earlier between different hESC lines (Allegrucci et al., 
2007; Osafune et al., 2008; Pal et al., 2009; Tavakoli et al., 2009; Lappalainen et al., 
2010). Nevertheless the exact reason for the down regulation of Cdkn1c remains 
unclear. 
Analyses of DMR1 of the H19/Igf2 locus in PG cells showed complete lack of 
methylation, which was in line with the PG origin. On the contrary, in N cells 
hypermethylation of CpGs in DMR1 of H19/Igf2 locus was observed. The transcript 
level of Igf2 was low and H19 gene expression was up regulated in PG cells, which 
were in line with PG origin. This indicates that various mechanisms apart from CpG 
methylation are regulating the allele-specific expression of H19/Igf2 (Reik et al., 
2000).  
One of the regulatory mechanisms controlling the allele-specific expression of 
H19/Igf2 involves CTCF, a transcriptional repressor which controls reciprocal allelic 
silencing of the Igf2 and H19 genes by binding to the H19 imprinting control region 
(Hark et al., 2000; Schoenherr et al., 2003). Another regulatory mechanism might 
involve a transcript that is antisense to Igf2 (Igf2-as). Igf2-as is maternally imprinted 
and it is transcribed in a reverse direction within the Igf2 gene (Okutsu et al., 2000). It 
is unclear if Igf2-as is translated into a protein, although it encodes a putative 
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polypeptide (Okutsu et al., 2000). It is speculated that putative Igf2-as peptide can 
regulate parent-of-origin-specific gene expression of Igf2 (Vu et al., 2003). 
Comparative analyses of various hESC lines indicated a substantial degree of 
epigenetic stability, despite differences in genetic background, derivation and 
expansion conditions (Rugg-Gunn et al., 2005; Kim et al., 2007). However, certain 
genomic loci were epigenetically more stable than others (Rugg-Gunn et al., 2005; 
Kim et al., 2007; Rugg-Gunn et al., 2007). For example, Kcnq1ot1 locus was shown 
to be stable while the H19/Ifg2 locus was unstable based on methylation patterns. 
The report further suggested that late passage hESCs are prone to hypermethylation 
in the DMR1 region of the H19/Ifg2 cluster. In my study the hESCs used were also of 
higher passages, therefore I also observed that the Kcnqot1 locus was epigenetically 
stable in PG and N cells while the H19/Ifg2 locus was not. The observed alterations 
of the methylation patterns in H19/Ifg2 DMR1 may have occurred during 
establishment and in vitro expansion of ESCs that can add heterogeneity to cells 
(Rugg-Gunn et al., 2005; Kim et al., 2007; Rugg-Gunn et al., 2007). Despite the 
irregularity of DMR methylation the gene expression of H19 and Igf2 in hpESCs and 
hpNSCs was consistent with a PG origin. Furthermore, other paternal (Snrpn and 
Nnat) and maternal (Dlx5, Gtl2, Ube3a and Kcnk9) imprinted genes maintained their 
parent-of-origin-specific gene expression pattern. However, Igf2r expression was 
elevated only in hpESCs but not in hpNSCs: the molecular basis was unclear. 
I observed that imprinted genes in hpESCs and hpNSCs upon differentiation 
maintained maternal-specific expression and imprinting-specific DNA-methylation. 
This suggests that either there is a less stringent role for imprinted gene expression 
during neural in vitro differentiation, or the balanced expression of imprinted genes is 
not required for differentiation to the stages analyzed. However in vivo animal 
transplant models are needed to assess the impact of imprinted genes on neural 
differentiation potential of hpESCs. 
 
6.5 Pluripotent stem cells 
Various types of human pluripotent stem cells derived from different sources and by 
different methodologies have been studied. They include hESCs (Thomson et al., 
1998), iPS cells (Takahashi et al., 2007; Yu et al., 2007), hpESCs (Kim et al., 2007; 
Lin et al., 2007; Mai et al., 2007; Revazova et al., 2007) and testis-derived 
pluripotent stem cells (Conrad et al., 2008) (Fig. 17). Although, mammalian SCNT-
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derived ESCs can be generated in multiple species, the derivation of hESCs through 
SCNT has failed so far (Cibelli 2007). However, Noggle et al., 2011 generated 
triploid pluripotent stem cells from human oocytes by injecting the diploid nucleus of 
an adult cell into an human oocyte with SCNT. But still a lot of obstacles that need to 
be overcome before obtaining diploid SCNT-derived ESCs (Daley et al., 2011; de 
Souza 2011).  
Transplantation studies involving hESC-derived NSCs into mice and rats indicated 
that the stem cell–based approach can induce considerable improvements in animal 
models with neurodegenerative disorders (Goldring et al., 2011). However, the 
clinical application of any type of stem cells to treat neurodegenerative diseases 
requires more detailed investigation, considering the complexity of the human brain 
structure and function and the alterations in the brain related to neurodegenerative 
diseases. Thus, in-depth transplantation studies are needed to understand the 
mechanisms regulating the proliferation, migration, differentiation, survival and 
function of ESC-derived donor cells. 
Another hurdle before clinical application of hESC-derived cells is graft rejection 
triggered by MHC antigens that induce T-cell responses finally leading to graft 
destruction (Kadereit et al., 2011; Tang et al., 2011). Taylor et al., 2005 predicted 
that 150 HLA heterozygous cell lines would provide a full match of MHC for less than 
20% of recipients. Therefore a large number of cell lines would be needed to cover 
the complete population, keeping in mind the diversity of HLA haplotypes specifically 
in different ethnic groups. 
Patient-specific iPS cells are generated by exogenous expression of combinations of 
transcription factors in somatic cells (Takahashi et al., 2007; Yu et al., 2007). iPS 
cells can provide the opportunity for specific individuals to undergo cell replacement 
therapy given that autologous transplantation of genetically identical cells does not 
lead to immune rejection (Yamanaka 2007). It has been estimated that a stem cell 
bank containing approximately 150 iPS cell lines with homozygous HLA haplotypes 
can provide histocompatible cells for vast majority of the population with minimum 
requirement of immunosuppression (Taylor et al., 2011; Taylor et al., 2012). 
Importantly, iPS cells can be utilized for future gene therapy strategies for known 
brain-specific genetic defects (Lengner 2010; Vitale et al., 2011; Marchetto et al., 
2012). Despite the previous enthusiasm for the application of iPS cells in 
regenerative medicine, differences between iPS cells and ESCs have been reported 
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(Chin et al., 2009; Doi et al., 2009; Hu et al., 2010). These differences prevent the 
use of common methodologies for iPS cells and hESCs. Moreover, reprogramming 
to iPS cells leaves traces of somatic cell identity, known as epigenetic memory 
(Barrero et al., 2011; Ohi et al., 2011; Panopoulos et al., 2011).  
hpESCs are an alternative method to generate  patient-specific pluripotent stem cells 
as they are an exact match to the oocyte donor’s genome (both nuclear and 
mitochondrial). hpESCs can be obtained without destroying a viable embryo and 
their derivation raises less ethical, socio-political and legal concerns in comparison to 
conventional hESCs. Furthermore, HLA homozygous hpESC lines can partially 
match at the MHC locus to a larger population of transplant recipients compared to 
conventional hESCs (Revazova et al., 2008). Furthermore, Nakajima et al., 2007 
described that HLA homozygous hpESC lines established from only 55 oocytes will 
provide matched donor cells for 80% of the patients. The number of hpESCs lines 
proposed by Nakajima et al., 2007  is considerably lesser than the number of hESCs 
(Taylor et al., 2005) and iPS cells (Taylor et al., 2011; Taylor et al., 2012) lines 
suggested for a pluripotent stem cell bank. Further detailed analyses of imprinted 
genes in hpESCs and hpESC-derived progenitor cells are needed to better address 
concerns about safety and differentiation efficiency of these cells in vivo before they 
can be considered as an alternative source for regenerative cell therapies. hpESCs 
provide a unique opportunity to study the role of maternal or paternal genome in 
organ development and to gain insights into a variety of imprinting-related disorders.  
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Fig. 17: Origin of various types of pluripotent stem cells. 
hESCs are isolated from the ICM of the blastocysts. hpESCs are derived from direct 
oocyte activation. ntESCs (nuclear-transfer embryonic stem cells) are formed by 
transferring the nucleus of a somatic cell into an enucleated oocyte (cross signifies 
that the strategy is not successful in humans). iPS cells can be obtained by 
transfecting the somatic cells with transcription factors such as Klf4, c-Myc, Oct4 and 
Sox2 which genetic reprogram the cells. Germline stem cells (GSC) are derived from 
adult testis by culture under specific conditions (adapted and modified from Muller et 
al., 2009). 
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6.6 Conclusion 
The results presented here demonstrate that despite the lack of paternal genome, 
hpESCs generate proliferating NSCs that are capable of differentiation into functional 
neuron-like cells and maintain allele-specific expression of imprinted genes. 
Additional studies are needed to further assess the in vivo functionality of hpESC-
derived neural cells. hpESCs can have important implications for studying the role of 
maternal and paternal genomes on neural development and to better understand the 
alterations in the structure and function of the brain due to imprinting-associated 
brain diseases. 
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7. MATERIAL AND METHODS 
7.1 Material  
7.1.1 Cell Lines 
Cell Line Cell Type Source 
phESC-3 
(LLC6P) 
Human parthenogenetic 
embryonic stem cells 
Revazova et al., 2007  
International Stem Cell 
Corporation, California 
phESC-6 
(LLC9P) 
Human parthenogenetic 
embryonic stem cells 
Revazova et al., 2007  
International Stem Cell 
Corporation, California 
 HFF-1 Human foreskin fibroblast ATCC-LGC Standards, Wesel, 
Germany 
 
7.1.2 Antibodies 
7.1.2.1 Primary Antibodies  
Specificity Clone Isotype Supplier 
GABA polyclonal Mouse IgG Sigma-Aldrich, Schnelldorf, 
Germany 
GFAP GA5 Mouse IgG Novocastra, Wetzlar, Germany 
Glutamate   Sigma-Aldrich 
HB9 polyclonal Goat IgG Santa cruz biotechnology, 
Heidelberg, Germany 
Human Nuclei 3E1.3 Mouse IgG Milipore , Billerica, MA, USA 
MAP2 AP-20 Mouse IgG Sigma-Aldrich  
Nestin 2C1.3A11 Mouse IgG  Abcam, Cambridge, UK 
NeuN A60 Mouse IgG Chemicon, Schwalbach, 
Germany  
Oct4 polyclonal goat IgG Santa cruz biotechnology 
O4 O4 Mouse IgM R&D Systems, Minneapolis, 
USA 
Sox1 polyclonal Rabbit IgG Milipore , Billerica, MA, USA 
Sox2 245610 Mouse IgG Abcam 
SSEA1 145-2C11 Hamster IgG BD Biosciences, Heidelberg, 
Germany 
Synapsin-1 polyclonal Rabbit IgG Synaptic Systems, Göttingen, 
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Germany) 
TH polyclonal Rabbit IgG Sigma-Aldrich  
Tubulin-ß-III Tuj 1 Mouse IgG R&D Systems 
Tau polyclonal Mouse Synaptic Systems 
Vimentin polyclonal Mouse IgG Abcam 
 
7.1.2.2 Secondary Antibodies 
Specificity Host Conjugate Supplier 
Goat IgG Donkey Cy3 Santa cruz biotechnology 
Goat IgG Donkey FITC Santa cruz biotechnology 
Mouse IgG Goat Cy3 Chemicon 
Mouse IgG Goat Cy5 Chemicon 
Rabbit IgG Goat Cy3 Chemicon 
Rabbit IgG Goat Cy5 Chemicon 
Rabbit IgG Goat Daylight488 Jackson Immunoresearch 
laboratory, Hamburg, Germany 
 
7.1.3 Cell Culture-related materials          
7.1.3.1 Media and Supplements Supplier 
Amino acids (non-essential) PAA Laboratories, Cölbe, Germany 
B27 supplement Gibco Invitrogen, Karlsruhe, Germany 
Dispase BD Biosciences  
DMEM/ F12 PAA Laboratories 
FCS cell-culture grade Biochrom, Berlin, Germany 
Knockout DMEM high glucose Gibco Invitrogen 
Knockout Serum replacement Gibco Invitrogen 
HEPES buffer (100 mM) PAA Laboratories 
L-glutamine (200 mM) PAA Laboratories 
ß-Mercaptoethanol Sigma-Aldrich 
N2 supplement Gibco Invitrogen 
Neurobasal Medium Gibco Invitrogen 
Non-Essential Amino Acids PAA Laboratories 
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PBS without Mg2+/Ca2+ PAA Laboratories 
Trypsin/EDTA PAA Laboratories 
Matrigel BD Biosciences 
 
7.1.3.2 Growth Factors Supplier 
Fibronectin Sigma-Aldrich 
Human BNDF R&D Systems 
Human EGF, recombinant PeproTech, Hamburg, Germany 
Human GNDF R&D Systems 
Human FGF-2, recombinant R&D Systems 
Human FGF-2, recombinant PeproTech 
Human FGF-8, recombinant PeproTech 
Human SHH PeproTech 
Human transferrin Sigma-Aldrich 
 
7.1.3.3 Medium for hpESCs culture 
Supplements Volume (500 mL) Final concentration 
Knockout-DMEM 380 mL - 
Knockout serum replacement 100 mL 20 % 
Amino acids (non-essential) 5 mL 1x 
L-Glutamine (200mM) 5 mL 2mM 
Penicillin (10KU/mL) 
Streptomycin (10mg/ml) 
5 mL 10 mL/L 
ß-Mercaptoethanol (14.3M) 
(3.5 ß-Merc. in 10 mL Hepes) 
5 mL 
(Sterile filtered) 
0.1 mM 
 
7.1.3.4 Medium for hpESC-derived embryoid bodies culture 
Supplements Volume (500 mL) Final concentration 
Knockout-DMEM 430 mL - 
Knockout serum replacement 50 mL 10 % 
Amino acids (non-essential) 5 mL 1x 
L-Glutamine (200mM) 5 mL 2mM 
Penicillin (10KU/mL) 5 mL 10 mL/L 
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Streptomycin (10mg/ml) 
 
7.1.4 Chemicals 
Chemicals Supplier 
Acetic acid PAA Laboratories 
Agarose Sigma-Aldrich 
Alkaline Phosphatase Kit Applichem, Darmstadt, Germany 
BSA Sigma-Aldrich 
Chloroform Applichem 
DAPI Sigma-Aldrich 
DNAse I Ambion, Austin, USA 
DNAse 10X buffer Ambion 
DNeasy Tissue Kit Ambion 
DEPC Sigma-Aldrich 
DMSO Applichem 
EZ DNA Methylation-Gold kit Zymo Research, Irvine, CA, USA 
EDTA Applichem 
Ethanol Applichem 
Ethidium bromide Merck, Darmstadt, Germany 
Fluorescence mounting medium Dako, Hamburg, Germany 
Glucose Applichem  
Glycerol Applichem 
Goat serum Sigma-Aldrich 
Isopropanol Applichem 
Laminin Sigma-Aldrich 
Methanol Applichem 
Mitomycin C Sigma-Aldrich 
Paraformaldehyde Applichem 
peq Gold RNA pure Peqlabs 
Phenol Applichem 
Poly-L-ornithine Sigma-Aldrich 
QPCR SYBR green mix ABgene, Hamburg, Germany 
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7.1.5 Consumables 
Consumables Supplier 
Bacteriological Petri dishes Greiner Bio One, Essen, Germany 
Cell culture flasks Sarstedt, Nümbrecht, Germany 
Nunc , Wiesbaden, Germany 
Centrifuge tubes (15 mL & 50 mL) Greiner Bio One 
Cover slip Hartenstein Laborbedarf, Würzburg, 
Germany 
Disposable gloves Kimberly-Clark, Koblenz, Germany 
Multi-well cell culture plates Nunc 
Parafilm M Hartenstein Laborbedarf 
Scalpels Ratiomed, Schossholte-stuckenbrock, 
Germany 
Sterile filter Schleicher & Schuell, Dassel, Germany 
Syringes B. Braun, Melsungen, Germany 
Tissue culture plates Greiner Bio One, BD Biosciences 
 
7.1.6 Instruments 
Instruments Supplier 
Cell freezing container Nalgene, Hereford, UK Cell culture 
EPC 10 double patch clamp 
amplifier 
HEKA, Lambrecht, Germany 
Centrifuges Eppendorf, Wesseling-Berzdorf and 
Thermo Scientific, Dreieich, Germany 
Sodium citrate Applichem 
Sodium hydroxide Applichem 
Retanoic acid Sigma-Aldrich 
Tetraethylammonium chloride Sigma-Aldrich 
Tetrodotoxin Sigma-Aldrich 
TissueTek O.C.T.  Sakura Finetek, Heppenheim, Germany  
Tris Applichem 
TritonX-100 Sigma-Aldrich 
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Confocal microscope Leica SP5, Wetzlar, Germany 
Digital weighting balance Sartorius, Göttingen, Germany 
Gene Rotor Real Time PCR Corbett Life Sciences (LTF     
Labortechnologie), Germany 
Incubator Thermo Scientific 
Inverted microscope Carl Zeiss, Jena, Germany 
Microscope EVOS, AMG, USA 
Neubauer chamber Marienfeld,Lauda-Königshofen,Germany 
Sterile bench Heraeus, Hanau, Germany 
Vortexer Scientific Industries, New York, USA 
Water bath GFL Gesellschaft für Labortechnik,   
Burgwedel, Germany 
 
7.1.7 Buffers and Solutions 
Phosphate buffered saline (PBS): 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 
mM KH2PO4, pH 7.3 in H2O. 
MPS buffer: 80 mM PIPES, 1 mM MgCl2, 5 mM EGTA, 0.5 % Triton X-100; pH 6.8 in 
H2O. 
10 mM Citrate buffer pH6: 9 mL 0.1 M citric acid in H2O + 41 mL 0.1 M Trisodium 
citrate dehydrate in H2O + 450 mL H2O. 
 
7.2 Methods 
7.2.1 Human foreskin fibroblast cell culture (HFF) 
HFF were cultured in HFF medium containing DMEM high glucose supplemented 
with 15 % cell culture-grade FCS, Penicillin (100 U/mL)/ Streptomycin (100 U/mL) 
and L-glutamine (2 mM). The fibroblasts were cultured at 37°C, 5 % CO2. Medium 
was changed twice a week. Cells were passaged at 1:4 -1:5 split ratio. For passage 
of HFFs, medium was removed, cells were washed once with PBS and 5 ml of 
Trypsin/EDTA was added. After 5 minutes at 37°C trypsinisation was stopped by 
adding 5 mL of HFF medium.  Cells were centrifuged at 700 rpm, resuspended in 
HFF medium and plated on tissue culture plates. To generate mitotically inactive 
feeder cells for culturing hpESCs, confluent HFF cultures plates were incubated at 
37°C, 5 % CO2 with 10 µg/mL mitomycin C in HFF medium for 2.5 hours.  Culture 
dishes were then washed twice with PBS and fresh HFF medium was added. 
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7.2.2 hpESC culture 
hpESCs (cell lines LLC6P (previously referred to as phESC-3) and LLC9P, phESC-
6) were derived and described by the International Stem Cell Corporation (Revazova 
et al. 2007).  hpESCs culture was performed as previously described with slight 
modifications (Revazova et al. 2007).  hpESCs were maintained on mitomycin C 
inactivated HFFs at 5% CO2 in medium containing Knockout-DMEM, 20% Knockout 
Serum replacement, 1% non-essential amino acids, 2 mM L-glutamine, 0.1 mM ß-
mercaptoethanol and 4 ng/mL FGF2. Cultures were passaged at a 1:3–1:4 split ratio 
every 5–7 days. Medium was changed every day. For passage of hpESCs, medium 
was removed cells were incubated with dispase. After 8-10 minutes, the reaction 
was stopped by centrifugation and removing the supernatant. Cells were washed 
once more with medium then resuspended in fresh medium and replated on 10 cm2 
culture dishes with mitomycin C inactivated HFFs. For AP staining the colonies were 
fixed and the activity of their AP was visualized by applying the Alkaline 
Phosphatase Kit according to manufacturer (see Material). 
 
7.2.3 Freezing of HFFs and hpESCs 
HFFs were spun down at 700 rpm for 5 minutes at 4°C and resuspend in 90% cell 
culture-grade FCS and 10% DMSO. Cells were frozen at densities ranging from 1 x 
106 / mL (min) to 5 x 106 / mL (max), approximately 1.5 mL per vial. Freezing took 
place in a freezing box with Isopropanol at -80°C for 3 days; afterwards vials were 
transferred in liquid nitrogen storage. hpESCs were frozen in 40% cell culture-grade 
FCS, 40% Knockout serum replacement and 20% DMSO. 
 
7.2.4 Thawing of hpESCs and HFFs from liquid nitrogen storage 
Vials with frozen cells were thawed rapidly in a water bath at 37°C, cell suspension 
were diluted with 5 mL appropriate cell culture medium, spun down at 700 RPM for 5 
minutes at 4°C, supernatant was removed and the cells were resuspended in 
appropriate cell culture medium, seeded and cultured. 
 
7.2.5 Neural in vitro differentiation 
Neural differentiation was performed as previously described (Koch et al. 2009) with 
slight modifications. Briefly, 4-day-old embryoid bodies were transferred to 
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polyornithine/laminin-coated tissue culture dishes and propagated in N2 medium 
containing DMEM/F12, N2 supplement (1:100) with 10 ng/mL FGF2. Within 10-12 
days, embryoid body outgrowths develop into neural tube-like structures. First signs 
of neural differentiation are small rosettes showing a columnar shape. These small 
rosettes become further organized and increase in size forming neural tube like 
structures with a central lumen and 3-dimensional growth. These structures were 
mechanically isolated with a needle. These clusters where further propagated as 
free-floating neurospheres in N2 medium containing 10 ng/mL FGF2 for 1 to 3 days. 
These neurospheres were distributed into single cells by incubating the spheres with 
trypsin/EDTA for 10 minutes. Neural stem cells were plated on polyornithine/laminin-
coated tissue culture dishes. Media was changed to neural stem cell medium 
(NSCM) containing DMEM/F12, N2 supplement (1:100), 1.6 g/L glucose, 10 ng/mL 
FGF2, 10 ng/mL EGF, and 1 µL/mL B27 supplement. High cell densities were 
essential during initial plating and media was changed daily. Passaging was 
performed at very high cell density and cells were split at a 1:2-1:3 ratio using 
trypsin/EDTA. Trypsin was inhibited by trypsin-inhibitor and cells were centrifuged at 
300Xg for 5 minutes at 4°C. Terminal differentiation of neural stem cells was 
performed in differentiation media containing DMEM/12 (N2 supplement; 1:50) and 
Neurobasal (B27 supplement; 1:50) mixed at 1:1 ratio. cAMP (300 ng/mL) was 
added to the media for 28 days. For induction of dopaminergic neurons (Perrier et al. 
2004), neural stem cells were cultured in N2 medium with addition of 200 ng/mL 
SHH, 100 ng/mL FGF8b, and 160 µM ascorbic acid for 8 days. Differentiation was 
performed for 20 days in differentiation media with addition of BDNF (20 ng/mL), 10 
ng/mL GDNF, 160 µM ascorbic acid, and 0.5 mM dibutyryl-cAMP. For induction of 
motoneurons (Li et al. 2005), 1 µM retinoic acid was added to NSCM for 6 days in 
the presence of additional B27 supplement (1:50) and adding 1 µg/mL SHH from day 
5. From day 7, media was changed to NSCM (without FGF2 and EGF) but with B27 
(1:50), 1 µg/mL SHH and 0.01 µM retinoic acid for another 6 days. SHH was 
reduced to 50 ng/mL for another 14 days, and cells were differentiated in the 
presence of 20 ng/mL BDNF and 20 ng/mL GDNF in differentiation media. 
 
7.2.6 Immunostaining of cultured cells 
Cover slips with differentiated cells were washed with PBS once. After removal of 
PBS, cells were permeabilized with 1 mL MSP buffer each well for 30 seconds. 
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Afterwards, cells were fixed with 1 mL Methanol for 3 minutes at –20°C and washed 
three times with 1 mL PBS + 0.1 % Triton X-100. For blocking unspecific binding, 
cells were treated with 0.1 % Triton X-100, 5 % goat serum in PBS. Then cells were 
incubated for 30 minutes with 250 μL of different primary antibodies. Another 
protocol followed for cells grown on coverslips was that the cells were fixed in 4 % 
formaldehyde, permeabilized in 0.1 % Triton-X and 0.2 % gelatin. Slides were 
stained with the following primary antibodies: mouse anti-Nestin (1:500), rabbit anti-
Sox1 (1:500), mouse anti-Sox2 (1:500), mouse anti-vimentin  (1:500), mouse anti-
NeuN (1:1000), mouse anti-Tuj1 (1:1000), mouse anti-MAP2 (1:1000), mouse anti-
GFAP (1:500), mouse anti-O4 (1:500), goat anti-Oct4 (1:200), mouse anti-SSEA1 
(1:500), rabbit anti-Synapsin1 (1:1000), mouse anti-Tau (1:500), rabbit anti-TH 
(1:500), goat anti-HB9 (1:500). After washing three times with 1 mL 0.1 % Triton X-
100 in PBS for 5 minutes, 250 μL of secondary antibodies: Anti-mouse Cy3, Cy5, 
and DyLight 488, anti-rabbit Cy3 and Cy5 and anti-goat Cy3 and FITC were used. 
The cells were incubated for 1hour in the dark at room temperature. Lastly, the cells 
were washed three times with 0.1 % Triton X-100 in PBS and after that, nuclei were 
stained with 1 mL DAPI-solution (5 mg/mL DAPI stock solution was diluted 1:500 in 
PBS with 0.1 % Triton X-100, yielding a DAPI concentration of 10 μg/mL) for 5 
minutes. Then cells were washed with PBS and cover slips were put upside down on 
a drop of Fluorescent Mounting Medium on slides. Fluorescent imaging was done 
using a SP5 Confocal Microscope.  
 
7.2.7 Brain sample preparation and Immunohistochemistry of cryosections 
Brains of NOD-SCID (NOD.Cg-prkdscid Il2rgtm1Wjl/Sz) mice with teratomas were 
fixed in 4 % (w/v) paraformaldehyde in PBS for a day, then for two days 
cryoprotected in 16 % (w/v) glucose in PBS. Afterwards the brains were embedded 
in TissueTek O.C.T and stored at – 80 °C. 10 µm thick sagittal cryosections were cut 
with a microtome at – 20 °C. Sections with teratomas were stained with hematoxylin-
eosin for histological analysis. Histological analysis was performed on hematoxylin-
eosin stained sections.  
hpESC-derived teratomas were assessed by immunohistochemical staining by 
human nuclei-specific antibody (HNu). Cryosections were thawed for 30 minutes at 
room temperature and then boiled in a microwave with 10mM sodium citrate buffer 
pH 6. The slides were cooled down to room temperature for 30 minutes. 
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Cryosections were washed once with water and three times with PBS. Followed by 2 
hour incubation with blocking solution containing PBS, 5% Goat Serum and 0,1% 
Triton-X, slides. Then the slides were incubated with 1:500 HNu antibody in blocking 
solution over night at 4°C in a moist chamber. To avoid evaporation slides were 
covered with parafilm. The day after, slides were rinsed three times in PBS and 
incubated for 1 hour with the blocking solution containing 1:200 Cy3-labelled goat 
anti-mouse secondary antibody. The slides were rinsed 3 times in PBS and 
incubated with DAPI for 5 minutes then again washed once with PBS. Lastly the 
cryosections were fixed in mowiol, an anti-bleaching reagent. 
 
7.2.8 RNA isolation 
Total RNAs were isolated from feeder-free cultures of hESCs or from hpESCs. 
Feeder cells were depleted by repeated passages on Matrigel-coated plates. Total 
RNA was isolated from hESCs (I3 and H9 cell lines), from hESC-derived neural stem 
cells (hNSCs) and from hpESCs and hpNSCs by using peqGOLD RNAPureTM. 
Passage numbers of hpESCs that were used to generate hpNSCs were identical. As 
controls, cDNA from human parthenogenetic neural crest stem cells (hpNCSCs) 
(isolated from attached EBs stage of differentiation), total RNA, human fetal brain 
(hFB), 18 weeks, female (Stratagene, Santa Clara, CA, USA) and human adipose 
tissue-derived mesenchymal stromal cells (hMSCs) were used. 1 million cells were 
washed once in PBS and pellet by centrifuging for 10 minutes at 5000 g (3500rpm). 
The cell pellet was resuspended in 700 µL of RNA peq gold, mix by gentle pipetting, 
and then incubated for 3 minutes. 100 µL of chloroform was added and mixed by 
gentle vortexing. Next, samples were centrifuged for 10 minutes at 20000 g 
(14000rpm). The supernatants were transferred to fresh tubes and equal volumes of 
isopropanol were added to the aqueous phase and mixed gently by inverting. The 
nucleic acid was left to precipitate at -20°C for 20 minutes. Following precipitation 
samples were centrifuged for 10 minutes at 20000 g (14000 rpm). Following 
centrifugation, the supernatant was discarded and the pellet was resuspended in 1 
mL of 70% ethanol. Samples were centrifuged for 10 minutes at 20000 g (14000 
rpm). The supernatant was discarded, the pellet was again resuspended with 1mL of 
ethanol for a second wash and centrifuged for 10 minutes at 20000xg (14000 rpm). 
Finally, the supernatant was decanted and the pellet was air dried and resuspended 
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in 20 µL DEPC-treated water. The extracted amounts of RNA in the samples were 
photometrically quantified using an Eppendorf BioPhotometer. 
 
7.2.9 DNAse treatment  
To remove any contaminating genomic DNA from total RNA, RNA samples were 
treated with RNAse-free recombinant DNAse. 1 µg of RNA was mixed with 1 µL of 
10X DNAse buffer, DEPC treated water was added to 12 µL and 1 µL (2U) of DNAse 
I was added. Samples were incubated for 30 minute at 37°C. DNAse was inactivated 
by adding 1 µL of 25mM EDTA and 10 minutes incubation at 65°C. Half of the 
reaction mix containing 0.5 µg RNA was used for cDNA synthesis.  
 
7.2.10 First strand synthesis  
Reverse transcription reaction to synthesize first cDNA strand from DNAse treated 
total RNA included 0.5 µg of RNA in 6.5 µL DEPC-water, 1µL (200 ng) of oligo dT 
(16-mer) and 5 µL of DEPC treated water, the reaction-mix was heated at 65°C for 5 
minutes to resolve all secondary RNA structures. Then 1 µL of dNTPs (10mM), 4 µL 
of 5X first strand synthesis buffer, 2 µL of 100mM DTT and 0.5 µL of M-MLV reverse 
transcriptase were added, yielding final 20 µL reaction-mix per sample. Samples 
were incubated for 1 hour at 37°C and cDNAs were subsequently stored at -20°C.   
 
7.2.11 Analysis of gene expression using semi-quantitative RT-PCR 
PCR reactions were run by using Taq Polymerase. PCR conditions used were 35 to 
40 cycles of denaturation at 94 °C for 1 minute, annealing temperatures at 58 °C to 
62 °C for 1 minute according to the primers, and elongation at 72 °C for 1 minute. 
GAPDH was used a house-keeping gene to compare the expression. Omission of 
transcriptase during RT or cDNA sample during PCR served as negative controls. All 
reactions were performed on a T3 thermocycler. Primers (Eurofins MWG Operon, 
Ebersberg, Germany) used were: Primers (Eurofins MWG Operon, Ebersberg, 
Germany) used were: Acta1 forward (f): 5’-CAG GGC CCG AGC CGA GAG TAG-3’, 
reverse (r): 5’-ATA CCG ACC ATG ACG CCC TGG TG-3’, Tm: 60°C; En1 f: 5’-GAC 
TCG CAG CAG CCT CTC-3’, r: 5’-GCC TGG AAC TCC GCC TTG-3’, 55.3°C; 
FoxD3 f: 5’-CTG GAA GAG AAG GAC AGC GAC GCA-3’, r: 5’-GCT GTT CTT GGG 
CTT GCT CGG G-3’, 60°C; Gapdh f: 5’-ACG ACC CCT TCA TTG ACC TCA ACT-3’, 
r: 5’- ATA TTT CTC GTG GTT CAC ACC CAT-3’, 60°C; GFAP f: 5’-GGC ACG TGC 
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GGG AGG CGG CC-3’, r: 5’-TCT CAT CAC ATC CTT GTG C-3’, 59°C; HoxA1 f: 5’-
GGG TGT CCT ACT CCC ACT CA-3’, r: 5’-GGA CCA TGG GAG ATG AGA GA-3’, 
62.4°C; HoxA2 f: 5’-TTC AGC AAA ATG CCC TCT CT-3’, r: 5’-TAG GCC AGC TCC 
ACA GTT CT-3’, 60.5°C; Musashi1 (MS1) f: 5’-GTC CTG TCG CCC ACC ATC TC-
3’, r: 5’-CCC TCC CAA CGC CAC TGA C-3’, 60°C; Nanog f: 5’-GCT TGC CTT GCT 
TTG AAG CA-3’, r: 5’-TTC TTG ACT GGG ACC TTG TC-3’, 57°C; Nestin f: 5’-AGA 
GGG GAA TTC CTG GAG-3’, r: 5’-CTG AGG ACC AGG ACT CTC TA-3’, 58°C; 
Nurr1 f: 5’-TTC TCC TTT AAG CAA TCG CCC-3’, r: 5’-AAG CCT TTG CAG CCC 
TCA CAG-3’, 60°C; Oct4 f: 5’-CGA CCA TCT GCC GCT TTG AG-3’, r: 5’-CCC CCT 
GTC CCC CAT TCC TA-3’, 62°C; Olig2 f: 5’-CAG AAG CGC TGA TGG TCA TA-3’, 
r: 5’-TCG GCA GTT TTG GGT TAT TC-3’, 60°C; Pax2 f: 5’-CAG GCA TCA GAG 
CAC AT C-3’, r: 5’-GTC ACG ACC AGT CAC AAC-3’, 55.7°C; Pax6 f: 5’-AAT AAC 
CTG CCT ATG CAA CCC-3’, r: 5’-AAC TTG AAC TGG AAC TGA CAC AC-3’, 59°C; 
Snai2 f: 5’-ATA CCA CAA CCA GAG ATC CTC A-3’, r: 5’-GAC TCA CTC GCC CCA 
AAG ATG-3’, 60°C; Sox1 f: 5’-TAC AGC ATG TCC TAC TCG CAG-3’, r: 5’-CTC 
TGG ACC AAA CTG TGG CG-3’, 61°C; S100B f: 5’- AAA GAG CAG GAG GTT GTG 
G A-3’, r: 5’- AGG AAA GGT TTG GCT GCT TT-3’, 60°C; Tuj1 f: 5’- CAA CAG CAC 
GGC CAT CCA GG-3’, r: 5’-CTT GGG GCC CTG GGC CTC CGA-3’, 60°C. 
Expression analyses of mitotic checkpoint and extracellular matrix genes by RT-PCR 
were performed using QuantiTect Primer Assays (Qiagen, Düsseldorf, Germany). 
 
7.2.12 Analysis of imprinted brain gene expression using quantitative RT-PCR 
RT-PCR reactions were performed and quantified using a Rotor-GeneTM 3000 and 
ABsoluteTM QPCR SYBR® Green Mix. PCR conditions used were 40 cycles of 
denaturation at 94 °C for 40 seconds, annealing temperatures at 60 °C for 40 
seconds and elongation at 72 °C for 1 minute. The relative gene expression levels 
were calculated with the 2-ΔΔCt method. The Ct-values indicate a difference of Ct-
values between reference gene and target gene. The housekeeping gene GAPDH 
was used as the reference gene. The expression level of target genes in hESCs and 
hNSCs was set to 1 in order to determine differences of the target gene expression 
in hpESCs and hpNSCs, respectively. The primer sequences (Eurofins MWG 
Operon, Ebersberg, Germany) used were: Cdkn1c f: 5'-TGA AGG ACC AGC CTC 
TCT CG-3’, r: 5’-TTC TCC TGC GCA GTT CTC TTG-3’; Dlx5 f: 5’-CCA ACC AGC 
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CAG AGA AAG AA-3’, r: 5’-GCA AGG CGA GGT ACT GAG TC-3’; GAPDH f: 5’-
GGA GTC AAC GGA TTT GGT CG-3’, r: 5’-TCC TGG AAG ATG GTG ATG GG-3’: 
Gtl2 f: 5’-ATC AGC CAA GCT TCT TGG AA-3’, r: 5’-AGC TTC CAT CCG CAG TTC 
T-3’; H19 f: 5’-CGG ACA CAA AAC CCT CTA GCT TGG AAA-3’, r: 5’-GCG TAA 
TGG AAT GCT TGA AGG CTG CTC-3’; Igf2 f: 5’-CTT GGA CTT TGA GTC AAA 
TTG G-3’, r: 5’-CCT CCT TTG GTC TTA CTG GG-3’; Igf2r f: 5’-CCA TTC AGA CAA 
CGA CGG ATA C-3’, r: 5’-ACG TTA TAT CCT TGC GAA CTG TTT AG-3’; Kcnk9 f: 
5’-CTA CTT TGC GAT CAC GGT CA-3’, r: 5’-GTA GCG CAC GAA GGT GTT C-3’; 
Kcnq1 f: 5’-TGT CCA CCA TCG AGC AGT ATG-3’, r: 5’-CCG TCC CGA AGA ACA 
CCA C-3’; Kcnq1ot1 f: 5’-CCA CCT TCT CCA TCT GCT CA-3’, r: 5’-AAT CCA GTG 
GGG AAA AGG TC-3’; Nnat f: 5’-AAT CAA AAC ACC GCA CCA G-3’, r: 5’-ATC 
AGT GAG GGG CAA GGG GGG TTC-3’; Snrpn f: 5’-TGG CAC CTT TAA GGC TTT 
TG-3’,  r: 5’-CCG CTT TTC TTC ACG CTC T-3’; Ube3a f; 5’-AGC CGG AAT CTA 
GAT TTC CA-3’, r: 5’-TGT CTG TGC CCG TTG TAA ACT-3’.  
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